var title_f16_23_16752="Pomeroy tubal ligation A";
var content_f16_23_16752=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F75414&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F75414&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pomeroy tubal ligation A",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 316px; height: 450px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHCATwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACioWuY1u47Yk+dIjSKMfwqVB5/wCBCpqACiqmqXn2G2WRY/NkeWOJE3bcl2C9cHpnP4VboAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAy1HmeJpGB/1Foqkf77k/8AtOtSsnSCJtW1m4Dhl85IBjtsQE/+PM35VrUAYOoXbXHi3TdLjK7IoXvrjI5ABCRj8WLH/gFXrQCbV72fJIiC26jPHA3sR/30B/wGuc8KXK3niHxhrkznyIrhdNiJ6CO2TL4/7ayTfl7V0mhwvFpcJmAE8uZpRjo7ncw/AnH4UAX6KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooqlrl39g0W/vMjMEDyDPqFJFAFfw0FbTGnXkXE804OMZDSMV/8dxVjWtRh0jRr7Uro4t7OB7iQ/7KKWP6Cn6TbtZ6VZ2znLQwpGec8hQP6Vw/x0nDeBl0gbjLrt/a6UgXOcSyrv6f7AegCTwpp80Hw28P6dc5a51PZLd9jmYmeYfq4/Gu+rBTM/jFYUCi30+xBwD0eViBx7LEf++q3qACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5r4gyf8SKC0xn7ffW1oRn+F5l3/8AjoaulrmfER+1eLvDFhjcsbz6g49BHH5ak/8AAph+VAHTV5v49A1L4l+CNNDf8es73zIc4OEfafw2MPxr0ivJNO1CG9+M3i7VpQz2vhzTxAzZ+6xQPgD1wJfzoA7fwkDcah4j1BuRPqDQx+yQosWP++1kP410lYPgS0ksvCGlR3AYXMkIuJw3XzZCZJM/8Cdq3qACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5bTCLz4ia5PglbCztrJSRwHYvK4B/3Whrqa5b4eZn07U9SOSdQ1O5mBPUoshiT/xyNaAOkuriK0tZri4cJDChkdj0VQMk/lXhfw7tpr34fahf3Kut/wCN9fkZtpwyQGQhh9FiilP413/xr1V9L+HWqCEkTXi/ZFx1wwO/Hv5Yc/hUXhTR/wCzr/wppBXaNF0cyyrnP76TagY+p+Wfn3NAHf0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBmeJ9Q/snw5qmoZwbW1kmHuVUkD86Z4S086T4X0mwZdr29rHG/u4UbifcnJrJ+JWLjQ7TS9pLarf29pj/Z3iSTP/bON66ygDy/4qA6v4r8MaEqF0aZZZQPRn/8AjUdxXVeFE+0614k1Vs/vrsWcfPHlwLt/9GGWuI0i/g1P4weKdUmc/wBn+HYcPJ2WQR7cf8BH2j/vqu7+Hlo9n4J0dJs+fJALiXPXfITI2f8AgTmgDoqKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoorB8b+J7Twl4fl1O8jknfesNtawjMlzO5wkSDuxP5DJ7UAZ+oEal8TNKtdpaLSbGW+c9lllPlRZ99gnrqL25isrOe6uG2wwRtK59FUZJ/IVzHw10vUrTQ5NQ8SRCPxFqkpur5RIJBGfupGpHRVQKAOcHPJJJOT8fdVk0z4WaylswW5vlFlET2MnDH8E3n8KAOJ8C2s918KNTvrpRFf+MtXKtgAHZLMI2BHsolb1xXvAAUAKAAOAB2rzp9IGl3fw18Owq7x2TSXMj+vk2zIWb3LzKfqa9GoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiuY8b+NdK8IwQreGW61O6ytlptqnmXN2/oiDt6k8CvIfFOn/FP4geI7HRrnULfwzo88Zury2sHZ5rSAnCLLKMB5Hw+FUgfKSaAPRPG/xNstE1EaF4ftJPEXiyUHy9LsmBMeOrTP0jUe/Pt3rz7w7p/iXxrep42+JGrrpWk+HL6Z7PT9MX5HaIlWfzMkuMgoMZLfMBjPPfT+H9I+F/w71FPCdisV66CGKZvmmuLmRhHGzv1Y73U+g7AVQ+JVxD4M8FeFtC0yMySS39rYWkW3d5sqgtHu9jIiFvUZoA2PEet3uo6rY2eklo9KgvoINTlDGORmf7sMbDoVJQv0ODtHJOPJf2r7+81PxP4P8AC+l3FtbToz6nJNdSBIY8cIzk9ANsn1z0r2C6tbTRtL0PRbedbm4j1G285nYGR5CzSNI/+0xVm/OvIbyOLxB8ftY1V7mK3NlcR6XbXBQM1ukSoZnTOR5jPKsSnBI80kcigDsfBXxCtfE/xG0Wz1azn0jxDDo9wJbO5UqrO8kBBhY8OrKjMCOw9q9irlPiD4M0Xxrpq2Gq4hvU/eWd5CwS5tnHR4268HGR0Ncz4B8ZalpniRvAvxAlT+34136fqO3ZHqsPZh2Eg6FfY0Aeo0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRWV4m8Q6V4Y0qTUdcvI7W1TgFuWduyoo5Zj2ABJoA1ScDJ6VwV94yvtfu59L+HsEN7JE/lXOsXGTZWp7hSOZpB/dU4B+8w6VVg0zW/iCwufEkdzovhZhmLRg+y5vB/eumHKKR/yyU/7xP3a9CtLaCztora0higt4lCRxRIFVFHQADgCgDm/B/guy8PTz3888+q6/dD/AErVbzDTSf7K44jQdkXAHv1rqaK5T4ieIx4f0m38m4jiv7qdY7dWIy2Pmfg9toIJ7A5oAxPG+r/bvHfhbw4sWIxfwX0ku4FZAsdw4THqGhVvyo+I9vDN8RPhq95KsdtHf3JG84DTfZ28sc98g4/SvnrW/Ft4fH+hL4St4b+70SRbgmSdFilBQJglmAyQXfAOQ0p9K9O8f+If+FreHJNO0Ow1awttPgk1e5vpoRG0UkIcRRxNkhmMqMCyHACHB5oA7PU9aefW/Dcd5IrSTeJriGBUTASOGCddrHucjP8AwL2ryXw+01h+0B8QJ7hBNbaKk2oW9rjPm3ErIY+frIfoSPQVR8BaZr1tfprl7etqh0TxSkMr3V1N5qwygQ+aFJ2HcJBk4B+Sup8SajpeiftJahYylEl16103LscYlS5jyv8AwJEB/CgD3XSdNkhsI3v5Ek1aSFVubuNApZ9oBKg5wMjgdPrXn/xH8KRa1pb6ZqD3jiH9/a30zq8ttKuNsscgwyNkfdYbTjAK8V0vgPV5NTmvjJ58jTEXrM7/ACQpIT5MSjsfKVHPu+e9dBrWnW+oWUqXFqLhtjBQG2scjkBu2enp60Acb8H/ABfd6/pdxpPiMCLxTpDCG9jI2mZSMx3Cj+664P1z04r0GvEfGqN4futN8b6Z50974bb7Lqo6SXOmuTncO7RnBwe6k9MV7VbTxXNvFPbuskMqB0dTkMpGQR+FAElFFFABRRRQAUUUUAFFFFABRRVDW7S8vbBotN1KTTbrcGSdIklxjsVYYIPtg+hFAF+iuHktviNaELbaj4X1NB1Nzaz2rHn1R3HT2qKfVviPA2F8LeHroesWsyJ+jQ0Ad7RXmt94z8c6XYy3ep+AbYQRDdI0WvQ/KB1Pzqo/WuA039qvw1PMqXug6xACcFoTHLj/AMeFAH0TRXlOl/H/AOHt8SJNWnscd7u0kQH2yAR+tdJpnxR8Dam6JZ+K9HaR+FR7lY2P4Ng0AdlRTIZY54llgkSSNhlXQggj2Ip9ABRRRQAUUUUAFFFFABRRXn/iTxnf3+qz+Hfh/bxahrMR2Xd/L/x56b/10Yffk9I159cYoA1PHvjiy8JQW8Ahk1HXL0+XYaVbczXL/T+FB3c8D9KyvCHgm8l1iPxT47ni1DxLj/R4I8m10xT/AAQqeresh5Pbjro+BfAdl4YmutRubmbV/Ed7zeardgebJ/soBxHGOyLx064FdhQAUUVyfxK8caf4E8Pm/vUe5u5T5VnYw8y3UuOFUDJx6nHA98AgDviL4ztfBehi6kglvdRuG8mx0+DmW6lx91R6DqT2HvgHxnwz4Q8SfELT9Z13xde/ZtXltsRWseHUwSIsqQjPEcTAhXVfnbnLjodzwjbz33iDxNrviC/fUPEK6Hv2/ZpIoNODmT91BuUHGFXLdW5PrXrOiaeln4fjNjEouZbSMHLHDMsQVc+nAA6UAeMeD7Wx0PwxrV1Y250PQ2uZJY721bzkhEkSSqlzA4KlB5m0NzgAZ29a1vhnYnT/AIc+MYDZxQX0VqkTQWrNIjf6DG6sowMFzIzFQOGY9ep7HwZok1loWs6FcpbSSeTDE6t80bsbOKNs9ypKH8Ki+FNt9nSZsc3Gm6bM5zkFxb+WT+UYoA8dstN83xf4h0+7l82B7UpNa263ZcFbiVTue3yIzxwWVsjoODXmPxYh1LVp9U1xNRN3c6FPbmWeW2WK7CSjbGWkXAkCGJQGwOZMkAkgfX/hrQ9P0PxrqyafFtkuLKGaeRjlpXae4bcx7nLH8OK5340aPHq1pqdrDDC17eaFc26Oy85M9vsyeuAxz7UAT/BfVW1HSoGt4UFtc2wvpJCTuG5vKgQD08uEk/8AAfevTK8a/Zbupb7wHNLcRmOW0lTSyCf+eEar/NjXstAHFahp8F1qt1b3x8+C+t5LCR1P+siclcH/AGkY7T/suD2NQfBO8uJfANrpl+c6hocsmj3Pu0DbFP4psP41ra/5llfLPYkszMskkKkAh+QpPoHAMZ9yp7GsjwoE0/4neKrSPIt9Vt7XWIR23FTDIf8AyHGfxoA72iiigAooooAKKKKACiiigAooooAKKKKAOXv/AAH4c1TVpNS1nT11S5Ztyi/dp44hjokbEoo+g71uWel6fYxCOysbW3jHIWKFUA/ACrlFAEUttBLG0csMTxsMFWUEEfSsS78E+FryF4rrw3o0sbnLK1jGcn1+71roKKAPLLz4L6TZzNdeCNW1fwleE7j/AGfcM0DH/ahclSPYYqKHXPiP4N/5GrSbfxXpCfe1DRV2Xca/3ntzw30SvWKKAMbwt4n0fxVp323Qb+K7hB2yKvDxN/ddD8yN7EA1s1x3ivwFY6xdHVNKuJtC8RqP3eqWOFdu+2Vfuyp6qwPsRXnc3xP8c+DNUt9P+Inh3TVspW8uPXLed47Vm7FyFfZu99uPTFAHutFcnb+JdZkhim/4RW5uIJQGSWyvraVGB5BBZ1yMd6bL4v1BFOPBXiVpOygWuD+PnUAddVPV9UsdG0+a/wBVu4bOziGXmmcKo/8Ar+g6muFm1z4javceRpHhSw0KAjm81i9WYj3WKEnJ9iwFbOi+C4o7qDUfE19L4g1qI7kuLlAsUDf9MYR8sf8Avct/tUAY07+IviBmOza78NeFHHNyRs1C+U/88wf9Qh/vH5yMYC9a7Tw7oemeHNJh0zRLOKzsoR8scY79yT1JPcnJPetKigAoorlPGHjO20G5t9LsYG1TxHecWumQH5yM48yQ8+XEOpc9umTxQAnxJ8e6L8PtAk1PXJwHIIt7VCPNuH/uqPyyeg7189+DNZuPGfiGXxhrplutc8xobC3ivZI4LSHaMrHFArTsw3EMSFBPc12GreELttU1jXPFF9FrWtCRoIm8kLDaeXZSzmOFTnC7ygyeTtyeTXpfwnsLDTPDEVraaPeaXeoiG9F3FiWabbzI0nIlyc/MCcdOOlAGN4L029l/4SyGZFE17ZQiIsLlcgrMoyLglhyD6D9a9E0qKSDTLOGYYljhRHGc8hQDVIBk8XOeNstiv5pIf/i616AMTS9v/CUa5txnZb5577W/+tWH8NnUveRRnKW9vBAO33WlHT8q6uz0+O2vr+7VmaS8dGbPRQqBQB+RP41xfwdmhvtK1a/t5llE186kj+EqASPzY/nQB0emEy+LtckwdsUNtbjnuBI5/wDRgrG8W7n8RQK0b+UFtIQ23hjJdqWAPssJJHoRW14UZ549UvHIIub+YocfwIREP/RefxqPxQjvd6ZI0O6zs3lvppD0UxxkIPrufP8AwE0AfP8A+z/qut6F8RPGmlwae9/oMl6lzMIMeZbNMTskVDy6YwGxkgAHsc/UFeGfCvTF0P4pPOZG/wCJzpRhdcfL59p5Ctg+4kJ/A17nQBzfiyJnkhKxElo3TehwWHVk+uAXU/3k965WfVmf4t+CZwRs1LSb+1faeDJG0LkfhtbFdf4stpZBZT2oZrmKQiJexYjcufT5kUZ9CfWuE8c+Vp/xZ+E+nW2Qom1BgvXC/Z8fl82KAPWqKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKjubeG6t5ILqKOaCRSrxyKGVh6EHgipKKAOf8J+E9P8KtfR6K1xDp9y4kSwMm6C2bnd5Sn7gYnJUHGegFdBRRQAUVyvxL8Rx+FvDH9pSPKALu2j2wrueQNMoKKPVhkfjXR2cssljDNeQi2maMNJFvD+WcZK7hwcetAE9R3E0VtBJNcSpFDGCzySMFVQOpJPQVyN745hvbiWw8FQx+IdTRtkphmAtbU+s0wyB/uruY46d64jWPBd/448RNpHizWpNSihRJdRt7UGCztQ2CkUSZLPI2CS7k7V6AFlwAGt/Fm88U68nhb4U2/wBsvpgxl1qaM/ZLWMHa8i5/1mDwD0JxjdWn8HvDVjpPiHxDcrNLfamrGCfUbht09xmWQ5c49FQADgBa7Hwf4cXRZr+ZoLeEu4t7WGAYS3tI8iKNR2zlnPu59BUvhGws7ZNRuLaEJczXkyzvnl9sr7c9uAaAMHW7SS8vtQtbaF5HXU0Zyq52JNaeSXI7gFiT7c12cNjGDZyzqr3VtEY1kHGMgbsD32j8qpWUZi8V6oflxLbW78dcgyqc/kK2KAMu8cR+ItN+XJlhnj3enKN/7LWpWHqsF1L4o0KSKBmtoluGmlBACEqoUH65P5VuUAVdV+0jTLz7Coe78l/JUtjL7TtGe3OK5L4Z6emh6DqkB2QrDdYcjkBkgiRmP4oSa7euSlUr4G1+Rcb5zesO3V3C/pigDe0C1hstEsbe2laaFIV2yt1kyM7j7nOfxqp40L/8ItqMUXElxH9mTnHzSERj9WFbESLHGiIMKoCj6CsTxKEuL/QrJywEt6JjjofKRpBn/gSpQB5jeRT23xU8JamHmNlHe38Ei5+RDNLJEjY9SUQZ+ntXqvhXWk8Q6FBqUcLQLK0i+WxyRskZDz/wHNeZeJLy2sfD0+vXWcacunX0hPZWvmlb/wAdwfxrtvhNbTWvw28OJcjE72aTSD/ak+c/+hUAdbXi/itX1D9o/wAHSpIRDpyT223qDI1tJI/5KYv++hXr15ex2klusv8Ay3fy1OehPTPsTgfUj1ry59KlsPi14Hiu2imv5ItV1G8lTIBkdYU+UHnaqkIM9loA9booooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKbI6xozyMFRQSzMcAAdzTqgvbS3v7SW1vYIri2lXbJFKoZXHoQeCKAPCvi34wbxVqen6T4Nhhvv7CceI7ya7LRW0sNuflWN8fvAXPVePl69ca3iSy8VeItRi0PxJq+nx2clr9qvItLheOO2gz9+RnLGR2IKovC5DMQdoFaPjWOzvfFsqaaYob42Evh6882MgQi4TfaycdY/MUpkcZcjqDXXaglhbu7bFW6uLqBL51QncY4/MA5/h2r245PcmgDU8NaNp3h/RLXTNGsorKygQKsEYwFPfPqT1JPJ61atLG2s5LqS2iWN7qXzpmGSXfaFyfwVR9BVTwwhGh2krjEtwv2mTP96T5z+WcfhWjFKkqlonV1DMpKnPIJBH4EEfhQA21mM8RcxvH8zLtcYPDEZ/HGfxqhpGU1DWIsKFFyrqAMcNEhJ/763VoQSrPHvTOMkc+xx/SsvTJ0fxHrUKn5ohAWH1U/wCFADC7L42CZ+V9OJxnuJR/8VWnNLKt5bxJHmJwxd8E7cYwPbOf0rKixJ44uvWHToe39+WT/wCNit2gCndZXUbJzfeQh3x/ZztxcMRkdecqFY8ds5q5THijkeN5I0Z423IzDJU4IyPQ4JH0Jp9ADJ5Vhgklf7qKWP0AzXPXFtdv4AeG0h82/ey3LEWA3Slc4yeOprR8TPs0C+4zviMQ+rfL/Wrl1bxzWbwOrmMrjbG5RjjsCCCPzoAnrmvGclrGtlNLefZ7y0868gjGMz7IXVkPHT94CfoK6UdPSsbxDbXd7Pp1rAsJspJg13vQltikOAD05KgEHqD7UAeY/EbSopvBepeHVlHn6zf6docJQcjYsTOT9FEp/CvZIIkghjijG2ONQqj0AGBXk9ru1b4p+GbYNugtor/xBIuc5Mj+RAfb5GfHuDXrdAHK+L0LXlvIj5aNO3JiJOVP0OxvxRa5uSdbj9pC1gd1P2bws8qJ1wz3SgnP0UV1+vwJJfwMrorlRE4Pclt0RPtvTH/AjXA6ftm/aeuJVBQL4SjKrjGAbnpigD12iiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA86+MPga88T6U1/4aufsXia2hMcMm7CXEed3kyeo3AMpP3WAPHNc9oXjaLxn4Xt7jUnudO8Q6BKYNX09/3eyR4nh3le6lnyD2P0rrfhpfNNqnjeymld5rPXZcK75KxvFG649By35Gs74rfDlPESzazoSLD4hW3e2lUP5aajbsMNbykeo+6/VSAe3AB2+kz7pFgUqI1tIJFUdRu3g/h8orSAA4AAHXivP/hVria3p1jOY5ILhLP7BcW87ZlhmtnKuj/7XzqfxFdhoV699ZyPKytLFcTQMVGBlJGUfoBQAvh945NFs3iOVaME/wC93/XNXFL+e4MYEe1SHzyx5yMe2Bz7+1QaVE8FikUi4ZSw7dNxweParW0bw3OcY6nH5UAJvUSBNw3kbguecev6ioZMDUISWPzRuoGeOqmnukC3CTOsQnIMaOQNxB5Kg9e2ce1R3gw9s+BlZR+oK/1oAs1BGkq3s7vcb4mVAkO0DyyM5Oepzx16banrJspJJPEmppLHBtiigETqn7wg7yQzdxkcD6+tACeLRcnQLg2ULT3CNG6RqMltrqcAfQGteq97NNDGjW9sbhjKiMocLtUsAz8/3QScd8YqATONeaHcxja2D47AhiM/U5/SgC/Wfr9w9ro91JCWExXy4tvXzGO1P/HiK0KwtVYXniDT7MsvkWim/uN3bGViz/wLe31joA4/4cWsVz8R/GmoQjda6alpoFqx7LDHvkH/AH3IPyr02uI+DsYfwWNSZNs2r3t1qUh/vebM5U/98bB+FdvQBz+tv/xOrWNoHIaPhweGO8EfQq4j5/2zXJ29vt/aOuLgBh53hVMg9iLo11PjAOIom3sqLuZCq5IYAkj8U3/iorHlBj+NemySEbrjw7Ony9MpcQk/+h0Ad3RRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeFeONci+GHx0sNcuz5Ph7xVbLa38h+7HcRHCSn0wrKD7Fj2r3ON1kRXjYMjAFWU5BB7ivGf2stBh1f4Wi7myn9m3sM5kAyUjZvLf/wBDB/4DWJ8NvHM3w28Tr8NPHl7HJbxhTo+rE4R4W+5HJn7voD2PHTBoA6H4oWMngbxhp/xG0yJ201XEGv20KZLxMNouAP7y8A+oC+hrv/AVwl9ocmo2+42l/dTXVszKV3xO5KPg8gMMMM9jW5qFpBqFhc2V5GsttcRNDLG3RkYEMD9QTXh3gPVdb+FL3eh+Ks3ngy0vHtrTVFJeTT0ODELgDpGysMOMhTkHAxgA94opsUiTRJJE6vG4DK6nIYHoQe4p1AFHWzs06ScAF7ciZc+qnP6jI/GprtA7W4ZsfvQR7kAnH6VX1+Qx6TPt3bn2xjb1+Zgv9alncf2laREE5SSQe2No/wDZqALdZyEJ4ilXABltUP12u3/xYrQZgqlmICgZJPAArMmZD4ksWXBL2twuRz0eL/69AFnVYbq4sZIrC5FtcMVxKV3bRuG7j1K5A9M01EzrUrk/ct0AHplm/wDiRV2qyFRfzsSB+6jBOfd/8aALNczr1hFp/hjxTdSzPLJdW9xNLI+BtURkKg9FVRj65PUmumrmvic6x/DbxW7lQo0m7yW6f6lqAE+GNsLP4b+FbcLt8vSrVSM558pc/rXTVz3w6nW5+H/hmaPO2TTLZhn3iWuhoAxvFELvYiVZvLjjzvyMqM9GPspwT/s7q5nWAtv4r8AagDti33WmNnqPMhLhT7hrcD613zqroyOoZGGCCMgivM/iCV0TRFg3SSz2M0er2O45LrburTJn+/5e/wCoyfWgD02imxSJNEkkTK8bgMrKcgg9CKdQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcT8bbUXnwj8XRMM402aUD3RS4/Va8y+PvhSPxx8MvC19bFI76K2E8UhTllNvvKE9gdoP4V7B8SEWT4eeKEkxsOl3QOR28pq4HRI7jVvgz4QlcSyRrogV3UgkyNEkSj3J3t+RoAu/s367DqPw5t9IkaVdX0J2sL+CaQu6SKxwcnnaR07DBA6V6fJawSCYSQROJl2ShkB8xcEYb1GCeD615FrFovhKa58daZGI10++uodWhQY+1WTzFi2O7xMxZfbcO4r162niubeK4t5FlglQPG6HIZSMgg9wRQB5yIJPhddiSBpZfAlzIFeAksdHkY43qev2ck8r/ATkfKSB6UDkZHSsDxrpurapokttoV3YwXDgq8d9befBPGQQ0bgEEAg9QfzrgPCXhb4r6folrpN94u0C3gtl8qO4isHuZ9g4UEuVU4GByCfUk80Aen66dukXUgIHlJ5uT22nd/SkWcTa4YkCkQ2wcsDn/WNx/6LNcXfeE/Hk1t5UHxFVSwKuZNDgYMPpkf1rgD8Nfil4duVOh+P5bvTpJg9wFtI/tCjGMosmVYAAYXcOOg7UAe5+IpI4vD+pyTECJLWVnJ6YCHNcV8NomtdI8I2M7lrqys7q2l7fMjRqc/ofxrO1LRfiTbWj295faP4u05mBkgIbS7mRR/CGQshB6EEAHNU9D8Z6PYePJ5/Ec0vhZ54HYadq8Pk5uHMYkkjnyY3QiJOAc5JPegD2KsTVlcR61jDEWiyICM4ID4/Va1LG8tb+2S4sbmG5t3+7LDIHU/Qjikltle5EwwGKGN+PvL6fn/AFoAmicSRJIvRlDD8axfGlnDqfh260y5AMOobbRwR1V2Ct/46TVjQbuKWwtIFc+clupKkdh8ufTqpp+ojzdR02Ex71EjTk5+7tUgfqwoA5H4DXbXPwm8PxykmeziaxlB6h4XaMj/AMdrv68h+Cl+9p4v8f8Ah6dGhjGpvq1gjn/WW8zMC6f7O5M/8Cr16gArlviT4en8ReGJYtOcR6tasLqwkboJ1Bwrf7LAsjD+65rpnlVJY0bO6TIX8Bmn0Aee/AbxC/iH4Z6Y10pj1CwL6fdwngxSRHbtP/Adp/GvQq8y1OOP4e/EH+2o8ReG/Esqw6lk4S1vekU/oqyfcY8DdtJ616bQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcn8WroWXwv8WTkE7dLuRx7xsP61ifC7Tbl/hD4GtAkYT7NazT7uMIB5gwO5LBB+JpP2i9QOnfBfxPIuN0sC24B7+Y6of0Y113ha1Gi+C9JtXDAWVhFGwbqNkYBz+VADNOsLXUvD+oWl3Gs1pfS3SSoejo8jqR+Irzr4D3eoeGvCFp4f8RTC4ddXutK03yzuk8uLeTvB6BfLf8ADaPSvU9AjaPRLESY8wxKz4GPmIyf1JryvwVp9zd/HvxhK8iyaRooBtkHRLm7jiaU+5xGc+m/3oA9R1TW9O0xGN3dRiRWCCFTulZj0VUHJY5GABXJ6v4tvI5TCRLbTM4RbW0jWadSRkB3Y+WrkYOwByAQa7U6fZHUBfG0tzehdguPKXzAvpuxnHtVDS/DmmaXqt9qNnC63V4xeRnlZwCTltgJITJ5OMZOPQUAcE0vi+4k32Hh/XCjDPnXOuRQHP8A1z8tgPyrq9G1zWYlWLxDoF5aoiDN4k8VyrHuWEeGH4Jj6VzXjDxxrmpa1d+F/hvpovNUgPlXurXBxZ6cxGcE/wAcgBztHTuDyK6TSfC+oHT7OLxL4j1HVLmGMK7W5+xJIw/iIiwx6d2x7UAdSrq4BRlYEAjBzwehqhr2iaX4g06Sw1uwtr+zfrFcRhx9Rnofcc1y2qfDXTLi4urnT9X8QaRfXcSwSXFnqUm91XJUfvNwGMt0A6mqg1Hxdo/iEwa5dWj6e/lw2NytuFgnc5ysxyWilY4APKE4AGTigDC0X4JWnhu5vm8JarqGiSlhLaXcFwzkE9YpomykqA8gnDYOCeAT0uh+LtS0vVbbQfH9tBZ6hcP5dlqVtn7HfnsozzFKf7jdf4SeldhpeoJfxyAxvBcwtsmgk+9G39QeoI4Ipuu6RYa9pNzpur2sd1Y3C7ZIpBkH0I9CDyCOQRkUAURbtYapby7SIPNkiDAAALKQwzj0kUD/AIHVq9WS1lvtSkdTHFa4iT+7jczE/X5f++a8zGo6j4f12HwV4q1Qtb3mBoWrzjm4UYzBKw489CFZXP3uO5IPoet3Rk8J6k5x5iwSRSD0bBU/4/lQB4L4+8RzeBfi34O1uWGQaVY2Uej6lNHHlQjqGyzexO4D/YNfScEsc8Mc0EiSRSKHR0YFWUjIII6g14p8TdCk8TfD/wAb2dvCr3txPCIN5xudbx1TntxgfjWp+y/FeRfCTTlvRFjfIqbJ5HZdrlCrK3CEFTwpxznjJoA9P1RHa1MkJAmhIkTLYBI/hJ9CMj8amtbiO6t0mhOUccZGCPUH0IPFSOqujI6hkYYIIyCKwtIKWeqTWSSloyTtyDncADtbP8QBBz/EDnqCSAaWsaZZ6zpV3pup26XNldRtFNE/RlIwR/8AX7V5PZ+KtS+FV7Bovjd5r7wm8nk6d4hPztCOiw3WB1GCN/cDnvj2TPOO9Yur6LFcw3AiggliuMi6s5lDQ3SkYIYHgN7/AJ57AGvBNFcQRzW8iSwyKGR0YMrA9CCOop9eOW2ha38MLmTUfB8dzq3gqY+Zc6CxJuLDJ+Z7bPUDnMZ/DJ5HqmhavYa9pFtqekXUd3Y3K74pYzkEf0IOQQeQQQaAL9FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeRftIRtqWi+FdAiP73VtftYSueqDczE+w4Nek+JW/4lZt8gG7kS2/B2Ct/46TXBeIf+Jx+0D4VsMhotE0q51R16gPKwhXPvjJFd54j0+51GygSymSC4iuoJ1dxkYSRSwx3yu4fjQBW8da8nhbwZrOtsqt9htXmRD0dwPkX8WwPxrD+EHh9/C3g+xstQ8yTWr9X1HUJypO+dyC+5sYyNwUD0Wq/xuC3HhzRtNkwYtS13T7SQH+JTOrEfiErqvEE7xwWk9tMyiC9hWYI33lZghU+w3g/hQBsVkeKtQuNO0aR7BUbUJnS2tQ4JXzZGCqWx/CCdx9gag8Q6/wD2PPgwebGltJcSYODwyIijtyX69sVLrbE6voMbMgja6clT1YiGQjH6n8KAKmg6FZ+D/DKxRSXEwtfNvLmct891KwZpJH9SxJOO3GOlJbjxPdRwzSy6fbZTzPKRWOc/8s3zzwP41I5/hIrO+KtzcP4dvdJt0aFr+zmEN6zhY0mXBWJj1BcbsHp8uO4rKvficsGm+Tc6ZPZazJsiUTui2251BV1myQYzlsEDJKkYzxQBzuq+KbJPHOn2fiu2Zp2P2YuIDIqg7tiyhchZVkXcrrjcrnGMkV2Wnajoni74cTw3TPDZSRm0ujapInkvnaShIyAD8wPbgmvnPxTqGs6j4rttQ8NeerarqSJaidkQF7cBkeOMZby9vKvnBJbJINe9/s8SXt78N4tV1GVZJtUu570FU2AKz7Rxk4+7n8aAJNPN9rWkyWjXs0HiTTJWtVvoHVPt8aFWBzyPmQoxU9Cf7pOew8Oap9vtRHO6tdIoZiF2+YpJAcL25BBX+FgR6E8vYW9laeL/ABBaaeIo7Gd4JbjyeGtbxwwEg7DcFQHjrg8hjVuGRtP1tpZxscFpZdvChvlWXA/usGjlA7FWz3oAp/GfwfD400LTdPvmRLAX8TTv914wW27kbseduO+72rzW91rxJ8MIbvQfG8cmpeHrqL7PZeIIwWyw4iFwM/K2MKT3wOuCa+gtStRe2E9uSAXXCkjIDdQfwODUet6Zbazo97pt9GkttdwtDIrqGBDDHQ0AcTCN9pqsg/eCS5ttrIchv9NkAIx2rn/2f7r7DqXi/wAM+YZIrS6j1GBm4bZcqWZfTAZTj/erM0HSrj4X6tB4Tvbya+0K+8k6LcunzxtHP5stu5XjOGZ1PoGHao/gwA/xu8amIkpb6ZYQyYHBcxqSfrncPzoA96rEuJDba9G1wsflzELG+OvYZ/2gTgH0k9q14Zo5t/lOrbGKNjsw6iqmpzQRS2nnIGk83MZOODjk/wDfJJ/CgBdWgV7c3AlFvNbgyJMeidyG9VOOR/UA07Sr5b+0EoAVx8rqG3ANgHg9wQQQe4INXK5uCGLSvFLmF5I7e7iVWgI+RXz8rJ7clSB0JX1oA0LuNtPupNQidvs7YNzEeRgceYPQgYz6georz/X1uPBHiC613w1ZTyabI5n1rSIgMSRnre26/wDPRf41H3u4zgn1MgMCGAIPBB71m32nM2nIlqyi6tstbM3QEdFP+yR8p9vegCxpGpWmsaXa6jps6XFldRrLDKh4ZSMg1brxrQbsfDjxxYaZEqReDPFMzmxiOR/Zt9gboAOgR2zhR0bI47+y0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRWL411tfDfhDWdZfB+w2ktwAf4mVSVH4nA/GgDhPhLE2rfED4jeKJTuSXUV0m2PYR2y7Wx7Fj+YNekagtq9zp4ulcyCctBt3YDhH5OOMbd33uM474rlPglo0mifC7w/b3BZrueD7ZcM33mlmJkbPvl8fhXcUAedfHcta+CrXWFjLrouqWepSAdQkcy7yPopJrp9eButI1a3jVpHe3NxbhB97CggA+u4f+PCtPV9OtdX0q803UIhNZ3cLQTRn+JGBBH5GuE+Hcl0bOTwlrU3/E68OlIGkbkXtkwIjl/4EgwfR0P0IBt+M7f7Ta291FgJNE9oWb+HzdpjbP8A10WMf8CNTaxOupeGbPV4sI1q8d9gkfJsP7xT7hTIv1rI+GbDUvBl74e1b99NpFzPo9wrcExof3R/GFozmpfDl7JpWt3eh6o25ZX3I8nR2b+L6SYJ9pBIO60Adhc29tf2jwXUUNzazLteORQ6Op7EHgivnbx/8M9WvNUWLwrp+mwRaVK8lteWtxJbywu67hAu7eowcMCNoBIHFezHWzoGvy2GvTpFp12wfTrtwEjU8Brd26BgeVJ+8GwOV519VlFvC9tZFYr6dJJYVC48xlwW59Tn69fSgD58+H/w28Z6bfS3b3fh7VLqKwlsHF+s8nmxuQUjyQNqqQ3TkcqR0x714L8PJ4X8NafpEVzLcR2kCQqzgDhR2A6D8z6k1sW0kc0KTw4KSqHBAxuBAwfyxSXcxggZlCtJgiNC4Xe2OFyfWgDldStIo9avr5Y2M9xCIpY4nJW7gj3ZAHQTIWYjHUceu2S6s7nU00+4CeZszHJIWCh4yrJv+hV92B9O1VWuo7hrm4tlaFWYXKgJ9wj5TLjs6NlZF9Oe/PX2sKxQkKDtdi5UtuAJ5IHtnNAEWnt9r0q1edQ5lhRmDDqSAeRVusfxCtza2Yv9OkZXslLtbD7k8YwWTGOGwDtI6H2yK07WeO6toriBt0UqB0b1UjINAHI/F7TrG98EXdzqN8+njTSL+K6QZaN0B6D+LcrMmO+/jnFcj+z54O1jw/J4m1jxHH5Wo63NDcGPH+qBQvsz32+ZtJ6ZUjtXUTx/8Jx4iiUhj4Y0e5DkkfLf3iHgD1jibnPRnH+wc8j8dviBf2dhN4d8I7hqV1NFp82oDdttpZiAkKFR/ripLdtqjPUqKAPV9EEhguJpoGgeed32N1wDtUn6hQfxqe/USRJEyblkcKSHClRycjPXp0FGl2n2DTLS0EjyfZ4Ui3uSWbaoGSTyTxUWpoXlsNoUkXAb5mAx8jZxnqcZ4FAF6qOs2IvrTAA8+JhLEc4wwORz6HofY1epsqCSJ4yzKGBXKnBGfQ9jQBm6hdvElheo5S38wLOhP8L/ACj8QxX8M1bmaG3uo5ZCVknIgB7Ejcw/r+dVbK1+06CLa5bd50bK7qeTuzlvY85x2NPSP+0NLtxI5EgaN2Yc4dGBP6qRQB538ftFbUfh5rsdopiuLWL+2LWSP7yzQMGYj3K+nqa77wlqw17wto+rLjF9aRXPHQF0DEfrWYt/beI9Dsr6SGSK3lmltLiJyNyZLwOp/wCB4FYnwLaez8Ef8I7fn/iYeHbqXS5/9oKd0bgejRuhFAHolFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXlHx3mfWT4Z8DWhzP4gv0NyAT8tpCRJKTj6Ae/Ner14V8ML7/hPfjr4t8VozPpWiwro+nN/CxJJdh9SrH6OKAPdAAoAUAAcADtS0UUAFeN/FmC70nx7pninR7kWt9aWYinYx70mgLP+7kAIJQuydOR1HIr2SuN8caUZ5ftkrReU5s7RVPJJN5GW/AjAH40AcDoXiY6X8cEbVNMvNGXxPYpBMsgD28t7Ef3bxzL8rhojtHQ5ABAJxXq/iPw/aa7FEJ8xzRH5JV6gZBK/Q4H0IBGCAa5+bwva+MfhnZaPqRkheOJBDcR8SW00XypKvowK5/Md6o+CPHc0etf8Ib45MNl4ugQGOQHEOpx8gTQn1OOU6g5wOCAAdJI4ijbR/E0K3ljcfuo7mWIPFOD0SYYwrdsn5W7YJ21yHi/T4NAu9N07RNS1zTFIa8QQQLeW1qsTKCxVyXRf3gBCHG0tkAc16lWH4otZdtpqtnC817prmVYkGWljYYkjHuRyP8AaVaAOR8M3M42wa3rUz+YvnJ9jCwxRFhkuhXJkiJOVbLAdGA6V0d/BdT2+y72yy7QFljbZHcqDlcHP7uQHBB6Z746VovCmhaqIdQ052Gn3DfaGt48eRIx/jVSMxP6lCp65zV/QPB+kaDO8umreLv3ZSS9mkj+bqNjMV/SgBdJ01pboXl0rLKOp27PMbGCzJjAbAAJUlW49BjfACgBQABwAO1KBgYHSigCtqlvNdadc29tcfZppY2RJtgfyyRjdg8HFeR/Evxppuhatp/ghtTudNtIrGOW4e2Vnu7pN3lx2sAAzvfBy46DpgnI9lrG1/QrHUT9te1iOowRMsNwIlaQKeqZI5U91PB/WgDi9D1fxJ4j02HS9D8NXPg/T4x5b3l2Yi0MY42QRKT+84xlsBMdGPFeYS+GdV0L4geEPB+k3UVxFHrr6pLcXRLPK0UQkaWTHVnSXZn+9GDxk17P4Db7VcXM8E7xJiKRrfllkjkiVo3y3IODjuflIJIArHi0qS6/aKuNR3MbWw8PxjaeizSzOMj32RkflQB0GoahJefErStGhuGjjsrKTU7hFOPMLHyYlPtzKfqFpnibddfEHwdZjlIReag4/wByMRL+twa434aXUuqfGjxrq0oBhuoFgtODlIreZ4D+DOjNXXWzNqHxfvXjwYNJ0hLdz6S3Eu8j/vmFD/wIUAafiTUZrfXvDFhbStG17eSebgAhokgkYg/8C2V0NcNqd39p+M+hadtP+h6Nd3pbry8sMa/TgPXZX95b6fZT3l9MkFrAhkllc4VFAySTQBS0wSRavqsL3AljLxzRx7gTEGXBGOuCysefX2q/B5SPJFG4Lg+YybsldxPOOwJB/WuA+DOsHxRp+veJZYHgl1DU5I0ikXa8cMIEcaMD0PDMR6sa2/DrPceN/FsxJ8uFrWzX0ysXmH/0fQBlaW/9kN47tUsn1BLW7OpRWq43SebEspRc9/MEhH1FHh+7tz8SHvbBg2n+JdHhv42PBaSFgpOPUxzRf981p6Cwf4h+KypBCQWMbAdm2ytz+DLXHwxnR9b8ORAeWul+IrnTEQHP+j3MDyoD7AmID/dFAHrdFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHDfGXxA+heB70WtwLe9vEeCKbvCuxmklx/sorEf7W0d6wf2YPD7aB8H9JM0YSfUGe/cY5w5+TP8AwAJXLfHK+m1u1WztXYHXb+Lw3p5AziLzA11OB3BZFj+iZ717xp9nDp9hbWVquy3t4lhjX0VQAB+QoAsUUUUAFMlijmCiWNHCsHAYZwwOQfqDT6CcDJ6UAZHhT/kCpg7h50/P/bV68f8Ajj8OIfFU0d7eiaHUnuZltLi3G+XYlsWijA9DJGxxwcua9g8IxmPw3p+4kl4/N5GPvkt/Wn6zZz3V7ozwBfLtrszTEtghfJkXj1O5l/DNAHz/APBbX/GJtrXQtW8W/YdaVpY4rLXtP85bhUYrmCcOpk2lSCpJOfavozT47mKxgS+njuLpUAlljj8tXbHJC5OB7ZNclD4Z0fxPoOpaXrljFd2yaldMm4FWiYys26NhyrDd1UisK7i8YfD2xnmhul8WeGYULNHf3C299axjriY/JKAOfn2t70AehWum2un313dwPJELtlMkRkPlGTONwU8KzZGcYyeTk81oV4j8OfHdvd6te+AtfTWbN5QW0efV4WjnljI3GJiSQzxnhXBO4KD1HPq+jat9rke1uV2XcC4kPRXZSVcr7A4P0dfWgDXooooAKKKy9dm1mIW66FZ2VwzsRK93cNEIhjhgFVi3Pbj60Acv8M5Y3k1MwurWsEcMCPnsplYc/wC4yVj/APCTQeH/AAj4h8cXA3XWtz40yA/enUL5VqgH+3gyewkJPQ1Y8W2Fx4T+HS2ltbTXtvcXSLq8tjERJHbyNiVoolycBcIFHKrzzt55yDStQ8Ua1ZeILq3MBtV26PoMxERgtCBieNgdplYDJ5OwYU9wQCf4XiHwoPE93rKz20XhvS7SwuXkAO5kSS5ndSPvbnnJH4Vc+B41P/hIfG914lhW31vULi21B4g5Pl28kX7lOe6bXU+6msbQtPTUPCfhjRo1cnxHrk2rXkUhzm0hkLlXxjIwlvH0A5ArZ+KuoS6DqPivUrWTy538L+UnOMzGd0i987pcD60AZXw6urvWvjVeeK3lV9M1mwu7XT0K4It7WeFA4Po7M7Y/xrsdVkbxn46fQFGdA0JorjU89Lq5IDwwe6qMSMO52Dpms21hs/BusaDDODFZeHvClw8p6nCtADz3P7tvqal8OXU3g74Rz67qEP8AxONRMmpyQ85e7unzHDz3BeOP/gNAGj8JWjOj+Ib8FVt7rXtQnRicAqJmTd9PkJrD/Z711vE1n401hZTJbXXiK4a39BEI4gmP+AgUX1g1noGgfC7Sbo/b7i0VtUuIyQ0FoD+/kz2aVyUX/fY/w0vw+1XSfCXw+8SeI7kJa6TLq97cQxxptyiy+TGiL3LeWAB3yKAKHgvVpf8AhpDxta5ZLG9s4vKOPlllt1jR8e483B/+tWh4nkJ8Z3EK4ymt6RNwvPzBlP6JWdoWh3+k+N/h1d6oFW/vLfVJb0KuCLicrOyn/d5Uf7tVtZ1qE/tExeHJj812bK9jKg5zDFckg4+qGgD3CiiigAooooAKKKKACiiigAooooAKKKKACsfxNeTw2SWtg2NQvX+zwH+5n70n0Rct9QB3rYrK06CW41G41G7RlPMNtGwwY48jJx2LMM/QL70AeU3FnDqf7Q3hvQrWMf2V4S0d7sITws0mEXPqduxvzNe114z8DX/t7x38SvFg3NDdakun2znoY4FxkfUFa9moAKKKKACmTxLNDJE+djqVbBwcEY60+igBkMSQwpFEoWNFCqo7AcAU+iigDE8Ktuh1NvXULgfk+P6Vr3NvDdW8lvdRRzQSKUeORQyup6gg8EVl+GrW4s4tRS5i8vffzyx8g7kZtwPH1rYoA8f8beFo/FXgfTdD85Le8tNUmtbC/GfMtJIvNMLKRyB8kan2OeoBqHwD4m1DX7e603XoRb+MtExFqdoy5+0IPlE6DHzI6/K2PVSOig94LCS0azW4HzzazLcKFy2FIkK59OAD+lV/H/gO18Utb6hZ3c2keJLIf6Hq1qP3kffY46PGT1U/pzQBHpGp3ED20sT3FxaNHsWGQHeUUn5QP+eqZ5H8aYIyRWkuvyuVj2RlpN5SSEFw6fwyIP48dGQfMDnqMZ88vvFup+FZY4/ivpy21q7CEeIdLy9rMc/J5sf34nHUMOh6cVLYfE3wHLeXMFx4sst5k/ijIS4HQSAqcb/9pSp9VoA7i2nlAlla8urdHPmNLAPtEDeuzILRn/ZPTPGa2baySSyj3T3chdkmLyyMj8EMAduMD1XAB6Eda8+1nxVaWoSbQreXUdRmmRLaS+fyy5PAEcfEkvBJ5GMclgBXp1ssi28YmkEsgUbnC7Qx9cdqAI9Rl8iymk2TvhekC7pOeMqO5HX8O/SuWa1gFurvJb/Yp23GQJvtZCeMsn/LJuT8ykDPXnit7XRcXFiI9Ou0huWbKfMAZMZJUHnB4z0PTkEZrnm1FbP7RJfA6dcoheeQRZikxyTJECc8D7yk+7DpQBzXw+8FXvh3xjYSapqUF3PbafcWlnDb5CW9l5qMitn7zknlsDIQVc8WeHdU8TfE21tzbeX4Zgtbaa+uXyDcPHM8qQIO43iNmPouO4rc+Hdj5kd7r0trawPqLAW4t1ZV+yoT5Rw3TduL44+8AeldjQB5b458Aa74n8epeDUbGDwzcWUVje25VzPJEk3msq/wjecKT/dHvVr4upq4v/Ck2k6DPrcFreST/Z4nCqtyIyLd5D2jVmZiexVTzXpFFAHleq2cvw3+HviTXri4bUvFupBfOvFXHmXUhEUKID92JGdQB6ZPU1T8J6FHq+taLoUY83w34IRIpX6pe6oEGT7+VlmP+2/+zXpvibQtO8TaHd6RrMH2iwuVCyJuKnggggjkEEAgj0o8N6Fp3hvRbXSdGt1trG3UhIwSTySSSTySSSSTySaAOX+IztaeJvAF+rhUTWTauD3E1tMg/XFcjpHh5r39qbX9alddmm6TbiNCvO6VSoIPsEf8/rXcfFiA/wDCIPqKoHk0e6t9VXIzhYJVd/8AyGH/ADqppSxyfGjWbm2dXjfQbMuUYEHM0+0/kDigDvKKKKACiiigAooooAKKKKACiiigAooooAK5v4k68fDHgHXtZRgstnZyPET/AM9MYT/x4iukryT9p13uPhvDotuT9p1vU7XT4lHUlpA3/slAG58BtDXQPhN4ctwMTT2y3kzHq0kv7wk+/wAwH4V39Q2dvHaWkFtCoWKFFjQDsAMD+VTUAFFFFABRRRQAUUUUAYej3sr+I9f0+UsywNDPEWOcJImNo9t0bH8a2pHWNGdzhVGSfQVSi0yOPXrnVVkfzZ7aK2aPjbhGdgfXP7wj8qv0AQ2dzFeWkNzbsWhmQSIxBGVIyDg81NRRQBW1KxtdTsJ7LUbeK5s50McsMqhldT1BB614dqXwu1LwBdahe/DzTrLVtGvXElxo90iNPAw/igkcHcMcFG7dDk5HvVFAHzxonxB8L6Z9oi1vw9c+ErzzN7Q3NibYb+peGdV+Q5z8rHac4BwTnfh+KPhO3sRPb+LLCW3Qlo9swjlQ9x5Z9emMFD2KV7O6q6lXUMp4IIyDWXd+HNDvCTd6Nps5PJ821Rv5igDyfUviv4D3SGXxDZiSVwziBJJo3ftmNfnR+nzITz1J6Va0yTV/iMun6fJa3g8LROtxfXuo2vlfbArBkhgVgJCpIG6RsZGRzmvUdO0DR9Nbdp2k6faN1zBbJGf0FaVACABQAoAA4AHaloooAKKKKACiiigBskaSxvHKivG4KsrDIYHqCKwfCPg/Q/CMd2nh+yFqty4aT94z8KMKoLE4VRnCjgZOK6CigAooooAKKKKACiiigAooooAKKKKACiiigAryv4gKda+M3w+0VRmGwFzrVwOuNihIj/32xr1SvNPB8Y1b40eN9ZIJTTre10aBuozt86UD/gTpxQB6XRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBFdXEVpazXFw4SGFDI7HoqgZJ/KuK+DFpMngaLU72Mx3uuXE2rzqeoM7lkH4R+WPwq18VGkuPCw0a3Zln1y4j0sFeqpIf3rfhEJD+FdbBFHBDHDCipFGoRFUYCgcACgB9FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFNkdYo3kkYKiAszE4AA6mgDmp1/tP4g2yYJg0a0aYkHjz58ovHqI1k/7+Cunrn/BcZk02bVJQ3m6rM1583URkARL+Eap+Oa6CgAooIooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArD8Xr9r01NKVir6lILU7Tz5ZBMn/jisM+pFblYlkf7Q8R3d0CGgsU+yRc/wDLQ4aU/h8i/g1AG0iqiKiKFRRgADAApaKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAGTB2hcRMEkKkKxGQD2OO9RadaLY2UVsjM4Qcu3V2PJY+5JJP1qxRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_23_16752=[""].join("\n");
var outline_f16_23_16752=null;
var title_f16_23_16753="Coronal CT of hamate fracture";
var content_f16_23_16753=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F60282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F60282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Coronal CT of hamate fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 317px; height: 334px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This coronal CT of the wrist shows two larger comminuted fragments (white arrows) and some smaller pieces, resulting from a fracture of the hamate (H). The base of the adjacent 5th metacarpal is also indicated (black arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin E Burroughs, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_23_16753=[""].join("\n");
var outline_f16_23_16753=null;
var title_f16_23_16754="Patient information: Monoclonal gammopathy of undetermined significance (The Basics)";
var content_f16_23_16754=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?23/6/23650\">",
"         Patient information: Bone density testing (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/12/36034\">",
"         Patient information: Calcium and vitamin D for bone health (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?9/63/10227\">",
"         Patient information: Cancer screening (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?28/26/29090\">",
"         Patient information: Multiple myeloma (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/58/35746\">",
"         Patient information: Osteoporosis (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?22/60/23491\">",
"         Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?12/16/12547\">",
"         Patient information: Multiple myeloma symptoms, diagnosis, and staging (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?30/40/31366\">",
"         Patient information: Multiple myeloma treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/49/25366\">",
"         Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Monoclonal gammopathy of undetermined significance (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H92701411\">",
"      <span class=\"h1\">",
"       What is monoclonal gammopathy of undetermined significance?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Monoclonal gammopathy of undetermined significance, called &ldquo;MGUS&rdquo; for short, is a condition that involves 1 type of white blood cell. White blood cells fight infections in the body. They are made in the bone marrow, which is the middle part of bones.",
"     </p>",
"     <p>",
"      When people have MGUS, their bone marrow makes too many of 1 type of white blood cell. These white blood cells make a protein called monoclonal protein (M-protein).",
"     </p>",
"     <p>",
"      MGUS causes no symptoms and, in most cases, does not lead to any problems. But in some cases, MGUS can turn into a serious condition. One serious condition is multiple myeloma, which is a cancer of the white blood cells involved in MGUS.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H92701426\">",
"      <span class=\"h1\">",
"       What are the symptoms of MGUS?",
"      </span>",
"      &nbsp;&mdash;&nbsp;MGUS does not cause any symptoms. Your doctor or nurse will suspect you have it after you have lab tests done for another reason.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H92701441\">",
"      <span class=\"h1\">",
"       Is there a test for MGUS?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If your doctor or nurse suspects you have MGUS from other lab test results, he or she will do an exam and further tests. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Blood tests",
"       </li>",
"       <li>",
"        Urine tests",
"       </li>",
"       <li>",
"        A bone marrow biopsy &ndash; For this test, a doctor takes a very small sample of the bone marrow. Then another doctor looks at the sample under a microscope to see which cells are present.",
"       </li>",
"       <li>",
"        Imaging tests, such as X-rays, CT scans, or MRI scans &ndash; Imaging tests create pictures of the inside of the body.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H92701456\">",
"      <span class=\"h1\">",
"       How is MGUS treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;MGUS does not need treatment. But your doctor will monitor your condition closely. That way, he or she will know if your MGUS turns into a serious condition that does need treatment.",
"     </p>",
"     <p>",
"      To monitor your condition, your doctor will talk with you and do exams on a regular basis. He or she might also order repeat blood and urine tests. How often these tests are done depends on your individual situation.",
"     </p>",
"     <p>",
"      People with MGUS have a higher-than-normal chance of breaking a bone. Because of this, your doctor will check you for osteoporosis, a disease that makes your bones weak. If you have osteoporosis, he or she will treat it. If you don&rsquo;t have osteoporosis, your doctor will recommend things you can do to help keep your bones strong. This includes getting enough calcium and vitamin D.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H92701471\">",
"      <span class=\"h1\">",
"       What symptoms should I watch for?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You should watch for symptoms that could mean your MGUS has changed into a serious condition. This change can happen quickly. Let your doctor or nurse know right away if you have any of the following symptoms:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Bone pain",
"       </li>",
"       <li>",
"        Feeling more tired or weak than usual",
"       </li>",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Night sweats that soak your clothes",
"       </li>",
"       <li>",
"        Headache or dizziness",
"       </li>",
"       <li>",
"        Weight loss",
"       </li>",
"       <li>",
"        Numbness, tingling, or weakness in the chest, lower back, or legs",
"       </li>",
"       <li>",
"        Blurry vision or trouble hearing",
"       </li>",
"       <li>",
"        Bleeding more than usual",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      These symptoms can also be caused by other conditions that are not serious. But your doctor or nurse will want to check that your MGUS hasn&rsquo;t changed into a condition that needs treatment.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H92701486\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?28/26/29090?source=see_link\">",
"       Patient information: Multiple myeloma (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/58/35746?source=see_link\">",
"       Patient information: Osteoporosis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/6/23650?source=see_link\">",
"       Patient information: Bone density testing (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/63/10227?source=see_link\">",
"       Patient information: Cancer screening (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/12/36034?source=see_link\">",
"       Patient information: Calcium and vitamin D for bone health (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?12/16/12547?source=see_link\">",
"       Patient information: Multiple myeloma symptoms, diagnosis, and staging (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?30/40/31366?source=see_link\">",
"       Patient information: Multiple myeloma treatment (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/49/25366?source=see_link\">",
"       Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?22/60/23491?source=see_link\">",
"       Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?16/23/16754?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 86741 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-115.25.216.6-E8883028DF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_23_16754=[""].join("\n");
var outline_f16_23_16754=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H92701411\">",
"      What is monoclonal gammopathy of undetermined significance?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H92701426\">",
"      What are the symptoms of MGUS?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H92701441\">",
"      Is there a test for MGUS?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H92701456\">",
"      How is MGUS treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H92701471\">",
"      What symptoms should I watch for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H92701486\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/6/23650?source=related_link\">",
"      Patient information: Bone density testing (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/60/23491?source=related_link\">",
"      Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/12/36034?source=related_link\">",
"      Patient information: Calcium and vitamin D for bone health (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/63/10227?source=related_link\">",
"      Patient information: Cancer screening (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?28/26/29090?source=related_link\">",
"      Patient information: Multiple myeloma (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/16/12547?source=related_link\">",
"      Patient information: Multiple myeloma symptoms, diagnosis, and staging (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/40/31366?source=related_link\">",
"      Patient information: Multiple myeloma treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/58/35746?source=related_link\">",
"      Patient information: Osteoporosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/49/25366?source=related_link\">",
"      Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_23_16755="Diphtheria cutaneous lesion 2";
var content_f16_23_16755=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F63145&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F63145&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    A diphtheria skin lesion on the leg",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention Public Health Image Library. Available at: file://phil.cdc.gov/phil/home.asp.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_23_16755=[""].join("\n");
var outline_f16_23_16755=null;
var title_f16_23_16756="Ingenol mebutate: Patient drug information";
var content_f16_23_16756=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ingenol mebutate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/35/38451?source=see_link\">",
"     see \"Ingenol mebutate: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F14204999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Picato&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F13831183\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3656442",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat skin harmed by the sun.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F13831182\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3656444",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ingenol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F13831187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3656465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have sunburn or other skin problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3656462",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Make sure sores near the area to be treated are healed before using this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F13831188\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697964",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in skin to hard and thick.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F13831189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F13831185\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3656445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a new tube of gel each time you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3656450",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on right after taking a shower or less than 2 hours before bedtime.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3656446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Allow gel to dry for 15 minutes after using.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696254",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3656447",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch area where gel was put on your skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3656464",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Leave on the skin for 6 hours, then wash off.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3656448",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid actions that may cause sweating for 6 hours after the gel is put on your skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694697",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not cover with dressings.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3656449",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not get this drug on other parts of your body or on other people.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F13831186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F13831190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699391",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away any part not used after use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F13831191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 83364 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-27.109.116.13-BBD231414A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_23_16756=[""].join("\n");
var outline_f16_23_16756=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14204999\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13831183\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13831182\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13831187\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13831188\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13831189\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13831185\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13831186\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13831190\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13831191\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?37/35/38451?source=related_link\">",
"      Ingenol mebutate: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_23_16757="Linear IgA bullous dermatosis close view";
var content_f16_23_16757=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F59901&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F59901&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Linear IgA bullous dermatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple tense bullae and erosions are present on the extremity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_23_16757=[""].join("\n");
var outline_f16_23_16757=null;
var title_f16_23_16758="Ghrelin";
var content_f16_23_16758=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ghrelin",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/23/16758/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/23/16758/contributors\">",
"     Rodger A Liddle, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/23/16758/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/23/16758/contributors\">",
"     F Xavier Pi-Sunyer, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/23/16758/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/23/16758/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/23/16758/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ghrelin is a 28 amino acid peptide that is the natural ligand for the growth hormone secretagogue (GHS) receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Based on its structure, it is a member of the motilin family of peptides. When administered peripherally or into the central nervous system, ghrelin stimulates secretion of growth hormone, increases food intake, and produces weight gain [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ghrelin, which is produced by the stomach, increases during periods of fasting or under conditions associated with negative energy balance such as starvation or anorexia. In contrast, ghrelin levels are low after eating or with hyperglycemia, and in obesity. Accumulating evidence indicates that ghrelin plays a central role in the neurohormonal regulation of food intake and energy homeostasis.",
"   </p>",
"   <p>",
"    This topic review will provide an overview on the biology of ghrelin. Related subjects are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13929?source=see_link\">",
"     \"Pathogenesis of obesity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/50/13094?source=see_link\">",
"     \"Physiology of leptin\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33866?source=see_link\">",
"     \"Drug therapy of obesity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TISSUE DISTRIBUTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ghrelin was discovered in 1999 when it was noted that tissue extracts from the rat stomach activated the GHS receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/1\">",
"     1",
"    </a>",
"    ]. It has since been recognized that the stomach is the richest source of ghrelin. Over 90 percent of the body's ghrelin is in the stomach and duodenum. Lower amounts are found in the pancreas, pituitary, kidney, and placenta. A limited region of the arcuate nucleus of the hypothalamus contains small amounts of ghrelin.",
"   </p>",
"   <p>",
"    Ghrelin is most abundant in the gastric fundus where it is produced in oxyntic glands by distinctive endocrine cells known as",
"    <span class=\"nowrap\">",
"     P/D1",
"    </span>",
"    cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Ghrelin-containing cells are of two types:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One is open to the lumen of the stomach where it is exposed to gastric contents.",
"     </li>",
"     <li>",
"      The second, closed type, is not open to the lumen of the gut, but rather lies in close approximation to the capillary network of the lamina propria [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/7\">",
"       7",
"      </a>",
"      ]. In this location, ghrelin is secreted into the vasculature.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     STRUCTURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ghrelin gene is on chromosome 3p and is translated into a pre-propeptide that has a signal peptide typical of secretory proteins. Ghrelin shares structural similarity with motilin although its 28 amino acid structure is unique. A distinctive feature is a fatty acid chain modification on the serine residue at position three that is necessary for biological activity (",
"    <a class=\"graphic graphic_figure graphicRef54191 \" href=\"UTD.htm?24/12/24781\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Obestatin is a 23 amino acid peptide that is also encoded by the ghrelin gene. Obestatin, originally isolated from the rat stomach, was initially thought to oppose the effects of ghrelin on food intake. Treatment of rats with obestatin suppresses food intake, inhibits jejunal contraction, and decreases weight gain [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/8\">",
"     8",
"    </a>",
"    ]. However, there is accumulating evidence that obestatin has multiple other effects. In the pancreas, obestatin is expressed along with ghrelin and may sustain &beta; cell survival [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/9\">",
"     9",
"    </a>",
"    ]. Obestatin is also produced in adipose tissue, where it appears to have",
"    <span class=\"nowrap\">",
"     autocrine/paracrine",
"    </span>",
"    effects to regulate growth and differentiation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/10\">",
"     10",
"    </a>",
"    ]. Elevated blood levels of obestatin have been reported in some cancers (eg, ovarian cancer) and it is possible that obestatin plays a paracrine role in cancer growth [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The ghrelin receptor (growth hormone secretagogue, GHS-R) is a member of a G protein-coupled receptor (GPCR) subfamily that also includes receptors for motilin, neurotensin, and neuromedin U. Two forms of the receptor (GHS-R1a and GHS-R1b) exist and result from alternative mRNA splicing from a single gene.",
"   </p>",
"   <p>",
"    GHS-R1a is expressed in both the central nervous system and peripheral tissues. In the brain, GHS-R1a expression is highest in the hypothalamus, but it is also found in the dorsal motor nucleus of the vagus and parasympathetic preganglionic neurons. In some hypothalamic nuclei, GHS-R1a mRNA is co-expressed with neuropeptide Y (NPY) where both peptides likely induce orexigenesis. In peripheral tissues, GHS-R1a is found in the pituitary, islet cells of the pancreas, thyroid, adrenal glands, and heart. GHS-R1b is a truncated form of the receptor and although it is more widely distributed than GHS-R1a, it does not interact with the G protein complex and thus its biological actions are unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     SECRETION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ghrelin concentrations in the blood increase during fasting and surges occur shortly before meals. Ghrelin secretion appears to be a cephalic response, possibly under sympathetic nervous system control [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/13\">",
"     13",
"    </a>",
"    ]. Preprandial ghrelin release can be entrained and may be important in preparing for meal ingestion [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ghrelin levels decrease after eating. The suppressive effects of food on plasma ghrelin appear to be nutrient specific, with carbohydrates having the greatest effect followed by protein and lipids. Postprandial suppression of ghrelin release is unrelated to meal effects on gastric distention or intraluminal nutrient exposure in either the stomach or duodenum, but rather occurs through nonvagal neural signals from the intestine [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ghrelin expression has been detected in some cancers, including the majority of gastric carcinoids and some intestinal and pancreatic neuroendocrine tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/16\">",
"     16",
"    </a>",
"    ]. In vitro studies have demonstrated a growth promoting effect of ghrelin and it has been speculated that ghrelin may potentiate cancer growth. In contrast, low baseline concentrations of ghrelin have been reportedly associated with gastric noncardia and esophagogastric junction cancers. This may be attributed to the finding that serum ghrelin levels decrease under conditions of chronic inflammation and atrophy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/38/618?source=see_link&amp;anchor=H2#H2\">",
"     \"Risk factors for gastric cancer\", section on 'Precursor lesions for intestinal type cancers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In lean individuals, fasting plasma ghrelin levels are approximately 550 to 650",
"    <span class=\"nowrap\">",
"     pg/mL.",
"    </span>",
"    Circulating ghrelin levels are low in obesity (in the range of 200 to 350",
"    <span class=\"nowrap\">",
"     pg/mL)",
"    </span>",
"    and states of positive energy balance, and are inversely correlated with body mass index (BMI) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. Decreased plasma ghrelin levels have been associated with gastritis, with or without Helicobacter pylori infection, and it has been proposed that serum ghrelin levels may be a useful marker of gastric atrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ghrelin levels are high in fasting, cachexia, and anorexia, where fasting ghrelin levels average over 1000",
"    <span class=\"nowrap\">",
"     pg/mL.",
"    </span>",
"    Importantly, weight-loss increases circulating ghrelin levels [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous administration of ghrelin potently stimulates growth hormone secretion and causes mild elevations of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/62/2023?source=see_link\">",
"     adrenocorticotropic hormone",
"    </a>",
"    (ACTH), cortisol, and prolactin [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/3\">",
"     3",
"    </a>",
"    ]. Together, ghrelin and growth hormone releasing hormone (GHRH) synergistically increase growth hormone levels [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/22\">",
"     22",
"    </a>",
"    ]. It is likely that ghrelin's effects on growth hormone release are mediated through neural afferent vagal pathways and may involve stimulation of GHRH [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Effects of ghrelin on food intake and energy balance",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to its effects on growth hormone secretion, ghrelin stimulates appetite and induces a positive energy balance that can lead to weight gain. Ghrelin is implicated in regulating mealtime hunger and meal initiation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/24\">",
"     24",
"    </a>",
"    ]. Ghrelin is the first hormone to be identified that increases feeding when administered peripherally. All of the other known orexigenic peptide transmitters, such as neuropeptide Y, orexin, agouti-related peptide (AGRP), melanocortin-concentrating hormone (MCH), and galanin, stimulate feeding only when administered into the central nervous system. The observations that circulating ghrelin levels increase sharply before a meal and fall abruptly after a meal suggest that ghrelin serves as a signal for initiation of feeding. Interestingly, ghrelin increases the number but not the size of meals. However, ghrelin does not only play a role in regulating short-term feeding, but it also regulates body weight over the long-term (see below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Adiposity",
"    </span>",
"    &nbsp;&mdash;&nbsp;In obese subjects, normal postprandial suppression of ghrelin is impaired [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/25\">",
"     25",
"    </a>",
"    ]. In addition, ghrelin can induce adiposity that is sustained as long as ghrelin levels are elevated, counteract decreases in energy storage, and prevent starvation and cachexia. Thus, ghrelin is the first hormone to be discovered that acts as a signal of starvation and it is likely involved in the long-term regulation of body mass [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Neuropeptide Y",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the central nervous system, ghrelin activates neuropeptide Y (NPY) and agouti-related protein-producing neurons in the arcuate nucleus of the hypothalamus, which is an important region of the brain involved in the regulation of feeding [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/4,27\">",
"     4,27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13929?source=see_link\">",
"     \"Pathogenesis of obesity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Effect of ghrelin on gastric motility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Like motilin, ghrelin stimulates gastric contraction and enhances stomach emptying. It also potentiates phase III-like contractile activity of the stomach and duodenum. These effects are mediated by vagal cholinergic pathways. The prokinetic effects of ghrelin oppose those of other gastrointestinal peptides, such as cholecystokinin, that serve as satiety signals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Effect of ghrelin on immune function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some evidence suggests that ghrelin may have direct anti-inflammatory effects [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. In one report, ghrelin receptors expressed on human T cells and monocytes mediated the inhibition of proinflammatory and anorectic cytokines, including interleukin 1 beta and tumor necrosis factor-alpha [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Effect of ghrelin on bone formation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Growth hormone is known to promote bone formation, raising the possibility that ghrelin may also affect bone metabolism. Interestingly, osteoblasts have been shown to express the ghrelin receptor GHS-R1a and ghrelin stimulates both osteoblast cell proliferation and differentiation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/30\">",
"     30",
"    </a>",
"    ]. Moreover, ghrelin was shown to increase bone mineral density in both normal and GH-deficient rats. In healthy adolescent girls and in those with anorexia nervosa (a disorder characterized by higher than normal ghrelin secretion), serum ghrelin concentrations appear to be an independent predictor of bone mineral density [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CLINICAL CONDITIONS AND APPLICATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Gastric bypass surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastric bypass surgery is a commonly used and successful treatment for morbid obesity. This operation creates a small gastric pouch drained by an intestinal limb so that only a small gastric reservoir remains and ingested food bypasses most of the stomach, all of the duodenum, and much of the jejunum. Gastric bypass patients exhibit different plasma ghrelin profiles [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/32\">",
"     32",
"    </a>",
"    ]. They lack the premeal increase in plasma ghrelin that is seen in normal individuals and cumulative ghrelin secretion is much lower. This lack of ghrelin response may be one of the mechanisms contributing to the overall effectiveness and negative energy balance seen after gastric bypass surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/31/33274?source=see_link\">",
"     \"Surgical management of severe obesity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Reduced ghrelin secretion following gastric bypass surgery may improve glucose tolerance. Under normal conditions, ghrelin stimulates secretion of insulin counterregulatory hormones, suppresses adiponectin secretion, and inhibits insulin secretion. These negative actions on insulin secretion are diminished when ghrelin release is impaired [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Prader-Willi syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prader-Willi syndrome is a congenital obesity syndrome that is characterized by severe hyperphagia, growth hormone deficiency, hypogonadism, dysmorphic features, and cognitive impairment. The genetic basis lies in the functional loss of several paternally expressed genes in an imprinted domain on chromosome 15 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/8/134?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of Prader-Willi syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/8/16516?source=see_link\">",
"     \"Epidemiology and genetics of Prader-Willi syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While obesity is usually accompanied by low ghrelin levels, that associated with Prader-Willi syndrome has high circulating ghrelin levels that do not decline after a meal [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. The levels of ghrelin in this syndrome are similar to those that would stimulate appetite and increase food intake in individuals receiving infusions of exogenous ghrelin; this suggests that abnormal ghrelin secretion may account for the hyperphagia in Prader-Willi syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/37\">",
"     37",
"    </a>",
"    ]. It is not known whether the persistently elevated ghrelin levels are responsible for the deficient growth hormone secretion that may occur through desensitization as has been seen with continuous GHRH stimulation of growth hormone release [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Applications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given that ghrelin is a major signal for stimulating food intake, promoting positive energy balance, and weight gain, it is reasonable to expect that ghrelin receptor antagonists will block the orexigenic signals from the gastrointestinal tract to the brain and, therefore, may be effective antiobesity therapies. As a result, development of ghrelin antagonists is an area of intensive investigation on the part of pharmaceutical companies. It will be of particular interest to determine if interventions that lower circulating ghrelin levels or ghrelin receptor antagonists will effectively treat the hyperphagia and obesity of Prader-Willi syndrome.",
"   </p>",
"   <p>",
"    It remains to be determined whether the administration of ghrelin, ghrelin analogues, or small molecule agonists will be useful to treat conditions of anorexia [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/39\">",
"     39",
"    </a>",
"    ]. Based on the effects of ghrelin on food intake and its ability to inhibit production of anorectic proinflammatory cytokines, there may be a role for ghrelin in the treatment of cachexia [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/40\">",
"     40",
"    </a>",
"    ]. Finally, advanced clinical trials are evaluating ghrelin agonists for the treatment of gastrointestinal motility disorders, including gastroparesis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16758/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12860451\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The stomach is the richest source of ghrelin. Over 90 percent of the body's ghrelin is in the stomach and duodenum. Ghrelin is most abundant in the gastric fundus where it is produced in oxyntic glands by distinctive endocrine cells known as",
"      <span class=\"nowrap\">",
"       P/D1",
"      </span>",
"      cells. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Tissue distribution'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ghrelin is a 28 amino acid peptide that is the natural ligand for the growth hormone secretagogue (GHS) receptor. The ghrelin receptor (growth hormone secretagogue, GHS-R) is a member of a G protein-coupled receptor (GPCR) subfamily that also includes receptors for motilin, neurotensin, and neuromedin U. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Structure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ghrelin concentrations in the blood increase during fasting and surge shortly before meals. Ghrelin levels decrease after eating. The suppressive effects of food on plasma ghrelin appear to be nutrient specific, with carbohydrates having the greatest effect followed by protein and lipids. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Secretion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ghrelin stimulates appetite and induces a positive energy balance that can lead to weight gain. Ghrelin is implicated in regulating mealtime hunger and meal initiation. Accumulating evidence indicates that ghrelin plays a central role in the neurohormonal regulation of food intake and energy homeostasis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Effects of ghrelin on food intake and energy balance'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/1\">",
"      Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402:656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/2\">",
"      Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB. Ghrelin--a hormone with multiple functions. Front Neuroendocrinol 2004; 25:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/3\">",
"      Takaya K, Ariyasu H, Kanamoto N, et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 2000; 85:4908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/4\">",
"      Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature 2001; 409:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/5\">",
"      Ariyasu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001; 86:4753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/6\">",
"      Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141:4255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/7\">",
"      Hosoda H, Kojima M, Kangawa K. Ghrelin and the regulation of food intake and energy balance. Mol Interv 2002; 2:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/8\">",
"      Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/9\">",
"      Granata R, Baragli A, Settanni F, et al. Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. J Mol Endocrinol 2010; 45:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/10\">",
"      Seim I, Walpole C, Amorim L, et al. The expanding roles of the ghrelin-gene derived peptide obestatin in health and disease. Mol Cell Endocrinol 2011; 340:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/11\">",
"      Markowska A, Zi&oacute;kowska A, Jaszczyska-Nowinka K, et al. Elevated blood plasma concentrations of active ghrelin and obestatin in benign ovarian neoplasms and ovarian cancers. Eur J Gynaecol Oncol 2009; 30:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/12\">",
"      Muccioli G, Baragli A, Granata R, et al. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors. Neuroendocrinology 2007; 86:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/13\">",
"      Mundinger TO, Cummings DE, Taborsky GJ Jr. Direct stimulation of ghrelin secretion by sympathetic nerves. Endocrinology 2006; 147:2893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/14\">",
"      Drazen DL, Vahl TP, D'Alessio DA, et al. Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology 2006; 147:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/15\">",
"      Cummings DE, Foster-Schubert KE, Overduin J. Ghrelin and energy balance: focus on current controversies. Curr Drug Targets 2005; 6:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/16\">",
"      Papotti M, Cassoni P, Volante M, et al. Ghrelin-producing endocrine tumors of the stomach and intestine. J Clin Endocrinol Metab 2001; 86:5052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/17\">",
"      Tsch&ouml;p M, Weyer C, Tataranni PA, et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/18\">",
"      Tsch&ouml;p M, Wawarta R, Riepl RL, et al. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 2001; 24:RC19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/19\">",
"      Otto B, Cuntz U, Fruehauf E, et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001; 145:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/20\">",
"      Checchi S, Montanaro A, Pasqui L, et al. Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J Clin Endocrinol Metab 2007; 92:4346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/21\">",
"      Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346:1623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/22\">",
"      Hataya Y, Akamizu T, Takaya K, et al. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 2001; 86:4552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/23\">",
"      Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002; 123:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/24\">",
"      Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 2007; 117:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/25\">",
"      le Roux CW, Patterson M, Vincent RP, et al. Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. J Clin Endocrinol Metab 2005; 90:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/26\">",
"      Wells T. Ghrelin - Defender of fat. Prog Lipid Res 2009; 48:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/27\">",
"      Kamegai J, Tamura H, Shimizu T, et al. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 2001; 50:2438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/28\">",
"      Granado M, Priego T, Mart&iacute;n AI, et al. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab 2005; 288:E486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/29\">",
"      Dixit VD, Schaffer EM, Pyle RS, et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004; 114:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/30\">",
"      Fukushima N, Hanada R, Teranishi H, et al. Ghrelin directly regulates bone formation. J Bone Miner Res 2005; 20:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/31\">",
"      Misra M, Miller KK, Stewart V, et al. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab 2005; 90:5082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/32\">",
"      Inui A, Asakawa A, Bowers CY, et al. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J 2004; 18:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/33\">",
"      Thaler JP, Cummings DE. Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009; 150:2518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/34\">",
"      Nicholls RD, Knepper JL. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu Rev Genomics Hum Genet 2001; 2:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/35\">",
"      Cummings DE, Clement K, Purnell JQ, et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 2002; 8:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/36\">",
"      DelParigi A, Tsch&ouml;p M, Heiman ML, et al. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome. J Clin Endocrinol Metab 2002; 87:5461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/37\">",
"      Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86:5992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/38\">",
"      Rittmaster RS, Loriaux DL, Merriam GR. Effect of continuous somatostatin and growth hormone-releasing hormone (GHRH) infusions on the subsequent growth hormone (GH) response to GHRH. Evidence for somatotroph desensitization independent of GH pool depletion. Neuroendocrinology 1987; 45:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/39\">",
"      van der Lely AJ, Tsch&ouml;p M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004; 25:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/40\">",
"      Akamizu T, Kangawa K. Ghrelin for cachexia. J Cachexia Sarcopenia Muscle 2010; 1:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16758/abstract/41\">",
"      Jeffery P, McDonald V, Tippett E, McGuckin M. Ghrelin in gastrointestinal disease. Mol Cell Endocrinol 2011; 340:35.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5380 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-218.28.111.102-322217C268-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_23_16758=[""].join("\n");
var outline_f16_23_16758=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12860451\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TISSUE DISTRIBUTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      STRUCTURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      SECRETION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ACTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Effects of ghrelin on food intake and energy balance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Adiposity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Neuropeptide Y",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Effect of ghrelin on gastric motility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Effect of ghrelin on immune function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Effect of ghrelin on bone formation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CLINICAL CONDITIONS AND APPLICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Gastric bypass surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Prader-Willi syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Applications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12860451\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/5380\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/5380|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/12/24781\" title=\"figure 1\">",
"      Protein structure ghrelin",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/8/134?source=related_link\">",
"      Clinical features, diagnosis, and treatment of Prader-Willi syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33866?source=related_link\">",
"      Drug therapy of obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/8/16516?source=related_link\">",
"      Epidemiology and genetics of Prader-Willi syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13929?source=related_link\">",
"      Pathogenesis of obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/50/13094?source=related_link\">",
"      Physiology of leptin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/38/618?source=related_link\">",
"      Risk factors for gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/31/33274?source=related_link\">",
"      Surgical management of severe obesity",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_23_16759="Xerosis";
var content_f16_23_16759=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F67366&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F67366&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Xerosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Dry, flaking skin is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_23_16759=[""].join("\n");
var outline_f16_23_16759=null;
var title_f16_23_16760="Plasmodium life cycle";
var content_f16_23_16760=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F70176&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F70176&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Life cycle of Plasmodium*",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 579px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    1. Plasmodium-infected Anopheles mosquito bites a human and transmits sporozoites into the bloodstream. 2. Sporozoites migrate through the blood to the liver where they invade hepatocytes and divide to form multinucleated schizonts (pre-erythrocytic stage). Atovaquone-proguanil and primaquine have activity against hepatic-stage schizonts. 3. Hypnozoites are a quiescent stage in the liver that exist only in the setting of P. vivax and P. ovale infection. This liver stage does not cause clinical symptoms, but with reactivation and release into the circulation, late-onset or relapsed disease can occur up to many months after initial infection. Primaquine is active against the quiescent hypnozoites of P. vivax and P. ovale. 4. The schizonts rupture and release merozoites into the circulation where they invade red blood cells. Within red cells, merozoites mature from ring forms to trophozoites to multinucleated schizonts (erythrocytic stage). Blood-stage schizonticides such as artemisinins, atovaquone-proguanil, doxycycline, mefloquine and chloroquine interrupt schizogony within red cells. 5. Some merozoites differentiate into male or female gametocytes. These cells are ingested by the Anopheles mosquito and mature in the midgut, where sporozoites develop and migrate to the salivary glands of the mosquito. The mosquito completes the cycle of transmission by biting another host.",
"    <div class=\"footnotes\">",
"     * There is strong evidence that drugs listed in parentheses are active against designated stage of parasitic life cycle.",
"     <br>",
"      &bull; Primaquine is a blood stage schizonticide with activity against schizonts of P. vivax but not those of P. falciparum.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_23_16760=[""].join("\n");
var outline_f16_23_16760=null;
var title_f16_23_16761="Hypertension after renal transplantation";
var content_f16_23_16761=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hypertension after renal transplantation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/23/16761/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/23/16761/contributors\">",
"     John Vella, MD, FACP, FRCP, FASN",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/23/16761/contributors\">",
"     Daniel C Brennan, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/23/16761/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/23/16761/contributors\">",
"     Barbara Murphy, MB, BAO, BCh, FRCPI",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/23/16761/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/23/16761/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/23/16761/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/23/16761/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 16, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The blood pressure frequently rises after kidney transplantation, as hypertension develops in up to 60 to 80 or more percent of renal allograft recipients (although the incidence varies in different populations). Poorly controlled blood pressure is common among kidney transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. In a single center study, for example, only 5 percent of kidney transplant patients were normotensive as defined by blood pressures less than",
"    <span class=\"nowrap\">",
"     130/80",
"    </span>",
"    mmHg as measured by ambulatory blood pressure monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Elevated blood pressure and pulse pressure can result in decreased allograft survival and left ventricular hypertrophy, with the latter being an independent risk factor for heart failure and death in the general population and renal transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/4-8\">",
"     4-8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17959?source=see_link\">",
"     \"Clinical implications and treatment of left ventricular hypertrophy in hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RISK FACTORS AND PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following risk factors have been associated with a higher incidence of posttransplant hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/5,9-13\">",
"     5,9-13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Delayed",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      chronic allograft dysfunction",
"     </li>",
"     <li>",
"      Deceased donor allografts, especially from a donor with a family history of hypertension",
"     </li>",
"     <li>",
"      Presence of native kidneys",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       Cyclosporine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      ,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      glucocorticoid therapy",
"     </li>",
"     <li>",
"      Increased body weight",
"     </li>",
"     <li>",
"      Renal artery stenosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There is suggestive evidence that the transplanted kidney may have prohypertensive or antihypertensive properties. Multiple cross-transplantation studies in experimental models of genetic hypertension have shown that the inherited tendency to hypertension resides primarily in the kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/14\">",
"     14",
"    </a>",
"    ]. A similar relationship may exist in humans. In one report, transplantation of a kidney from normotensive donors with a negative family history of hypertension led to prolonged normotension in six recipients with a prior history of end-stage renal disease due to benign nephrosclerosis and resistant hypertension while on dialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A larger study of 85 patients found that elevations in blood pressure and increased antihypertensive drug requirements occurred much more frequently in recipients from \"normotensive\" families who received a kidney from a donor with a \"hypertensive family;\" a family history of hypertension in the recipient blunted the effect of a \"hypertensive\" kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/16\">",
"     16",
"    </a>",
"    ]. A follow-up study found that a \"hypertensive\" kidney transplanted into a recipient from a \"normotensive\" family had a greater hypertensive response during an acute rejection episode than did all other donor recipient combinations [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism by which genetic factors affect renal function and predispose to the development of hypertension are not known. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/60/9159?source=see_link\">",
"     \"Genetic factors in the pathogenesis of essential hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The importance of other factors that promote the development of hypertension varies at different times after transplantation. In the immediate posttransplant period, for example, an acute elevation in blood pressure usually reflects volume overload, graft dysfunction due to rejection, ischemia, or calcineurin-inhibitor toxicity. Reversal of rejection or removal of excess fluid with diuretics or dialysis will lower the blood pressure in many cases [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies in cardiac transplants suggest that sympathetic activation may be an additional factor that can raise the blood pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/18\">",
"     18",
"    </a>",
"    ]. An alternate hypothesis is that the increase in vascular resistance results in inadequate relaxation rather than active vasoconstriction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Role of glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients need maintenance antihypertensive therapy, especially if pulse or high-dose daily glucocorticoids,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"      cyclosporine",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"      tacrolimus",
"     </a>",
"    </span>",
"    are given. Glucocorticoids are usually not a major risk factor for chronic hypertension in transplant recipients because of rapid dose reduction. They may, however, play a contributory role since gradual withdrawal of glucocorticoid therapy from stable renal transplant recipients results in a fall in blood pressure in most patients; this effect is greatest in those with preexisting hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/20\">",
"     20",
"    </a>",
"    ]. However, in a randomized trial of steroid avoidance or continuation with 5 mg daily from three months, there was no difference in the incidence of hypertension or number of drugs needed to manage hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Role of calcineurin inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to the introduction of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    for maintenance immunosuppressive therapy, posttransplant hypertension was most often mediated by activation of the renin-angiotensin system, either in the native kidneys or in the rejecting allograft [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/22\">",
"     22",
"    </a>",
"    ]. Although these factors may still contribute, calcineurin inhibitors play a predominant role if administered, raising the blood pressure in almost all patients and producing overt hypertension in many cases [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/10,11,23\">",
"     10,11,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The importance of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    can be appreciated from results in bone marrow and cardiac transplantation, settings in which renal dysfunction is less likely to be present. The incidence of hypertension after these procedures was below 10 percent prior to the availability of cyclosporine, but is approximately 30 to 60 percent after bone marrow transplantation and 70 to 100 percent after cardiac transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/11,24\">",
"     11,24",
"    </a>",
"    ]. Although blood pressure is reportedly lower with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    than with cyclosporine [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/25\">",
"     25",
"    </a>",
"    ], the combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    and tacrolimus can exacerbate underlying hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41945?source=see_link\">",
"     \"Cyclosporine and tacrolimus nephrotoxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     Cyclosporine",
"    </a>",
"    acts by increasing both systemic and renal vascular (primarily affecting the afferent arteriole) resistance. How this occurs is incompletely understood. Increased release of vasoconstrictors, particularly endothelin, has been thought to play an important role [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. As an example, cyclosporine continues to induce transient renal vasoconstriction with prolonged therapy in humans; this response is temporally related to an elevation in urinary endothelin excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/29\">",
"     29",
"    </a>",
"    ]. A pathogenetic role for endothelin in this setting is suggested by the observation in rats that the administration of an endothelin receptor antagonist blunts the rise in blood pressure induced by cyclosporine [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Additional factors may include increased sodium transport in the loop of Henle [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     RENAL ARTERY STENOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Posttransplant hypertension due to renal transplant artery stenosis is important to identify because it is a correctable form of hypertension. Although it can present at any time, renal artery stenosis usually becomes evident between three months and two years posttransplant [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk factors for renal transplant artery stenosis include difficulties in harvesting and operative techniques (such as improper suturing and trauma), atherosclerotic disease, cytomegalovirus (CMV) infection, and delayed allograft function [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/13,31,32\">",
"     13,31,32",
"    </a>",
"    ]. In a retrospective study of 29 recipients with stenosis and a case-control group of 58 patients, an increased risk of stenosis was significantly associated with CMV infection (41 versus 12 percent) and delayed function (48 versus 16 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prevalence of anastomotic renal transplant artery stenosis is difficult to assess. This is due in part to discrepancies in the definition of hemodynamically significant lesions and the use of different diagnostic modalities. It has been suggested that functionally significant stenosis occurs in up to 12 percent of transplant recipients with hypertension, with a range of incidence from 1 to 23 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with other causes of bilateral renal artery stenosis or unilateral stenosis in a solitary kidney, the administration of an angiotensin converting enzyme (ACE) inhibitor or angiotensin II receptor blocker (ARB) to a patient with transplant renal artery stenosis can lead to a reversible decline in glomerular filtration rate [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/23,33\">",
"     23,33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/60/19398?source=see_link\">",
"     \"Renal effects of ACE inhibitors in hypertension\"",
"    </a>",
"    .) Thus, an elevation in plasma creatinine concentration in this setting is suggestive but not diagnostic of renovascular disease in the graft. Persistent uncontrolled hypertension, flash pulmonary edema, and an acute elevation in blood pressure are other common features of this disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although various different imaging techniques may be utilized to diagnose renal artery stenosis, arteriography is the preferred modality. However, since arteriography is invasive, magnetic resonance arteriography or CT angiography are increasingly utilized techniques to screen",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diagnose transplant recipients for the presence of renovascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/23,32\">",
"     23,32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Arteriography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal arteriography remains the procedure of choice for establishing the diagnosis of renal artery stenosis in the solitary transplanted kidney. A renal allograft biopsy is generally performed prior to angiography to rule out chronic rejection or other form of renal parenchymal disease. These findings decrease the likelihood of a successful response to correction of a stenosis and therefore are relative contraindications to intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/9,35\">",
"     9,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As previously mentioned, however, given the invasiveness of arteriography, several alternatives for the diagnosis of renal artery stenosis have been evaluated. These include ultrasonography, magnetic resonance imaging, spiral CT angiography, and radioisotope renography. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/17/31001?source=see_link\">",
"     \"Establishing the diagnosis of renovascular hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some centers, Doppler ultrasonography is the preferred screening modality for stenosis of the transplanted renal artery [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/32,36-38\">",
"     32,36-38",
"    </a>",
"    ]. Data suggest that this technique is highly accurate, but is highly dependent upon the experience of the ultrasonographer. In one prospective study of 109 patients, the detection of stenosis with color Doppler ultrasonography was compared with intraarterial digital subtraction angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/37\">",
"     37",
"    </a>",
"    ]. When renal artery stenosis was defined as more than a 50 percent reduction in vessel diameter, the finding of a peak systolic velocity of &ge;2.5",
"    <span class=\"nowrap\">",
"     m/sec",
"    </span>",
"    was associated with a sensitivity and specificity of 100 and 95 percent for the detection of stenosis, respectively. In general, reported sensitivities have ranged from 58 to 100 percent, while specificity ranges from 87 to 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;As in the nontransplant population, magnetic resonance angiography (MRA) can be utilized to screen for renal artery stenosis among transplant recipients. Technical improvements have resulted in enhanced detection of significant renal artery disease. In one study of nine transplant patients, for example, combined analysis using gadolinium-enhanced MRA and three-dimensional phase contrast post-gadolinium had a sensitivity and specificity of 100 percent in detecting stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the administration of gadolinium during MR imaging has been strongly linked to an often severe disease called nephrogenic systemic fibrosis among patients with moderate to severe renal disease, particularly those requiring dialysis. As a result, it is recommended that gadolinium-based imaging be avoided, if possible, in patients with an estimated glomerular filtration rate less than 30",
"    <span class=\"nowrap\">",
"     mL/min.",
"    </span>",
"    There is no consensus among experts concerning the decision to administer gadolinium among patients with an estimated glomerular filtration rate between 30 and 60",
"    <span class=\"nowrap\">",
"     mL/min.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31082?source=see_link\">",
"     \"Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Spiral CT angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spiral CT angiography may be a useful noninvasive alternative to arteriography [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/32,40\">",
"     32,40",
"    </a>",
"    ]. Most of the available published data have evaluated this technique in native kidneys. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/17/31001?source=see_link\">",
"     \"Establishing the diagnosis of renovascular hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Radioisotope renography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radioisotope renography, performed before and after an ACE inhibitor, is not sufficiently sensitive if the history is very suggestive for renal artery stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Evaluation of a small number of patients suggests that renography may be more useful in predicting the physiologic significance of a moderately severe stenotic lesion, as patients with a negative renogram are unlikely to respond to correction of the stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The options available to correct stenosis of the renal artery include angioplasty (with or without stenting) and surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Angioplasty",
"    </span>",
"    &nbsp;&mdash;&nbsp;Percutaneous balloon angioplasty may be technically successful in up to 80 percent of cases, although 20 percent will develop recurrent stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/35,43\">",
"     35,43",
"    </a>",
"    ]. This technique is also less successful in the patient with arterial kinking, anastomotic structures, and long lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/44\">",
"     44",
"    </a>",
"    ]. Repeat angioplasty is usually not successful in such patients.",
"   </p>",
"   <p>",
"    The success of stent placement used in combination with angioplasty for a wide variety of vascular lesions suggests that deployment of metallic stents may be useful [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/45,46\">",
"     45,46",
"    </a>",
"    ], particularly in those with recurrent stenosis of the transplant renal artery [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Stent deployment in six consecutive patients with recurrent stenosis was evaluated in a retrospective study [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/47\">",
"     47",
"    </a>",
"    ]. At almost three years postprocedure, all arteries were patent without significant stenosis, and no additional interventions were required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The extensive fibrosis and scarring around the transplanted kidney makes surgical correction of a transplant artery stenosis difficult. Surgery should therefore be considered only in patients with resistant hypertension or with proximal recipient arteriosclerotic disease. Success rates have ranged from 60 to 90 percent. However, recurrent stenosis may occur in approximately 10 percent and graft loss has been reported in up to 30 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/44,49\">",
"     44,49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DEFINITIONS AND GOALS OF THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Goal blood pressure is based in part upon the presence or absence of proteinuria",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    additional comorbid conditions, such as diabetes mellitus",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    atherosclerotic cardiovascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/3,50\">",
"     3,50",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    guidelines recommend that the target blood pressure should be less than",
"    <span class=\"nowrap\">",
"     130/80",
"    </span>",
"    mmHg [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/51\">",
"     51",
"    </a>",
"    ]. For those with significant proteinuria (greater than a spot urine total protein to creatinine ratio of 500 to 1000",
"    <span class=\"nowrap\">",
"     mg/g),",
"    </span>",
"    the",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    work group suggests that a lower systolic blood pressure goal should be considered. The European best practice guidelines recommend a blood pressure goal of less than",
"    <span class=\"nowrap\">",
"     125/75",
"    </span>",
"    mmHg for proteinuric patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/52\">",
"     52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/45/21210?source=see_link\">",
"     \"Treatment of hypertension in patients with diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Posttransplant hypertension should be treated to protect against cardiovascular disease and against possible hypertensive injury to the graft. It has been suggested that long-term renal allograft survival may be negatively influenced by posttransplant hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. There is experimental evidence to support this hypothesis. In an animal model of chronic renal allograft rejection, antihypertensive therapy improved graft survival and function, diminished glomerular injury, and reduced proteinuria [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are also clinical data showing benefits with blood pressure control. This was best shown in a study of nearly 25,000 first deceased donor kidney recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/56\">",
"     56",
"    </a>",
"    ]. Among patients with systolic blood pressures &gt;140 mmHg at one year post-transplant, improved long-term allograft outcome was observed among patients with systolic pressures controlled to less than 140 mmHg at three years versus those with sustained increases in systolic pressure (RR of 0.79, 95% CI of 0.73-0.86).",
"   </p>",
"   <p>",
"    We use the following approach to the treatment of hypertension in the renal transplant recipient; this approach assumes that acute rejection is not thought to contribute to the elevation in blood pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. It also assumes that the glucocorticoid dose is being reduced to a low maintenance level both to reduce the blood pressure and to minimize other metabolic complications, which might have adverse cardiovascular effects, such as glucose intolerance and hyperlipidemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Patient is taking a calcineurin inhibitor",
"    </span>",
"    &nbsp;&mdash;&nbsp;An attempt should be made to reduce the calcineurin inhibitor dose in hypertensive patients receiving one of these agents. If the patient remains hypertensive, therapy with a calcium channel blocker (taking into account the drug interactions noted above) or a diuretic (with concurrent salt restriction) should be begun.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Calcium channel blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many physicians prefer a calcium channel blocker [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/10,11\">",
"     10,11",
"    </a>",
"    ] because, in addition to proven antihypertensive efficacy, it minimizes",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    -induced renal vasoconstriction (",
"    <a class=\"graphic graphic_figure graphicRef65894 \" href=\"UTD.htm?37/42/38573\">",
"     figure 1",
"    </a>",
"    ). A large number of studies have evaluated the efficacy of calcium channel blockers in kidney transplant patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/57-64\">",
"     57-64",
"    </a>",
"    ]. A 2009 systematic review of 29 studies with 2262 patients that compared calcium channel blockers to placebo or no treatment as well as seven studies with 405 patients that compared calcium channel blockers with ACE inhibitors found that calcium channel blockers were the most effective antihypertensive agent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/64\">",
"     64",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Compared with placebo or no treatment, calcium channel blockers were associated with a significant decrease in allograft loss (RR 0.75, 95% CI 0.59-0.99) and improvement in GFR (mean difference of 4.45",
"      <span class=\"nowrap\">",
"       mL/min,",
"      </span>",
"      95% CI 2.22-6.68).",
"     </li>",
"     <li>",
"      Compared with calcium channel blockers, ACE inhibitors were associated with a decrease in GFR (mean difference of 11.48",
"      <span class=\"nowrap\">",
"       mL/min,",
"      </span>",
"      95% CI -5.75 to -7.21) and increased incidence of hyperkalemia (RR 3.76, 95% CI 1.89-7.43).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This systematic review included studies in which patients were not taking a calcineurin inhibitor.",
"   </p>",
"   <p>",
"    When a calcium channel blocker is used, there may be a drug interaction with",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"      cyclosporine",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"      tacrolimus",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"      sirolimus",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"UTD.htm?6/4/6218?source=see_link\">",
"      everolimus",
"     </a>",
"    </span>",
"    (a metabolite of sirolimus) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/63\">",
"     63",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"     Verapamil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/16/12554?source=see_link\">",
"     diltiazem",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/61/42969?source=see_link\">",
"     nicardipine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/18/296?source=see_link\">",
"     amlodipine",
"    </a>",
"    (to a minor extent), but not",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12377?source=see_link\">",
"     nifedipine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/56/903?source=see_link\">",
"     isradipine",
"    </a>",
"    , slow",
"    <span class=\"nowrap\">",
"     cyclosporine/tacrolimus",
"    </span>",
"    metabolism and elevate the plasma cyclosporine concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/63,65\">",
"     63,65",
"    </a>",
"    ]. Some physicians have recommended the use of nifedipine or isradipine to prevent this interaction, while others prefer verapamil or diltiazem since the inhibition of",
"    <span class=\"nowrap\">",
"     cyclosporine/tacrolimus",
"    </span>",
"    metabolism permits the use of lower cyclosporine doses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/43/43706?source=see_link\">",
"     \"Maintenance immunosuppressive therapy in renal transplantation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     ACE inhibitors/ARBs and other agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other antihypertensive drugs can be added if the blood pressure is not controlled with a calcium channel blocker. The role of ACE",
"    <span class=\"nowrap\">",
"     inhibitors/angiotensin",
"    </span>",
"    II receptor blockers in the transplant patient is incompletely defined. These drugs effectively lower the blood pressure and experiments in animals suggest that they may partially protect against",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    nephrotoxicity when compared to similar blood pressure control with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/4/8263?source=see_link\">",
"     hydrochlorothiazide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/35/16950?source=see_link\">",
"     reserpine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/5/32848?source=see_link\">",
"     minoxidil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/57/15254?source=see_link\">",
"     hydralazine",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/66,67\">",
"     66,67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, there are several potential risks with ACE",
"    <span class=\"nowrap\">",
"     inhibitors/angiotensin",
"    </span>",
"    II receptor blockers in calcineurin-inhibitor treated patients.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The combination of ACE inhibition and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      -induced vascular disease can induce a modest decline in glomerular filtration rate via the same mechanism described above for renal artery stenosis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/68\">",
"       68",
"      </a>",
"      ]. Early after transplantation (within three to six months post-transplantation), the increase in serum creatinine concentration may confound the ability to accurately detect acute rejection.",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"        Cyclosporine",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"        tacrolimus",
"       </a>",
"      </span>",
"      tends to raise the plasma potassium concentration, primarily by decreasing urinary potassium excretion. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41945?source=see_link\">",
"       \"Cyclosporine and tacrolimus nephrotoxicity\"",
"      </a>",
"      .) This effect can be exacerbated by an ACE inhibitor, which reduces angiotensin II production and subsequent aldosterone secretion. Thus, ACE inhibitors should be avoided in patients who already have a plasma potassium concentration above 5.0",
"      <span class=\"nowrap\">",
"       meq/L.",
"      </span>",
"     </li>",
"     <li>",
"      ACE inhibitors can induce anemia in transplant recipients, lowering the hematocrit by as much as 5 to 10 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/69\">",
"       69",
"      </a>",
"      ] via an effect that may be enhanced by",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/70\">",
"       70",
"      </a>",
"      ]. Why this occurs is incompletely understood but a similar phenomenon probably accounts for the efficacy of ACE inhibition in posttransplant erythrocytosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/38/10857?source=see_link\">",
"       \"Erythrocytosis following renal transplantation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    To assess the safety and efficacy of ACE inhibitors and angiotensin II receptor blockers (ARBs) in kidney transplant recipients, a large number of retrospective and prospective studies have been performed [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/61,64,71-75\">",
"     61,64,71-75",
"    </a>",
"    ]. The magnitude of these effects was evaluated in a 2009 systematic review of 10 studies with 445 patients that compared angiotensin converting enzyme inhibitors to placebo or no treatment and of 7 studies with 405 patients that compared angiotensin converting enzyme inhibitors to calcium channel blockers [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/64\">",
"     64",
"    </a>",
"    ]. The following results were reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Compared with calcium channel blockers, angiotensin converting enzyme inhibitors were associated with a decrease in GFR (mean difference of 11.48",
"      <span class=\"nowrap\">",
"       mL/min,",
"      </span>",
"      95% CI -5.75 to -7.21), proteinuria level (mean difference of -0.28",
"      <span class=\"nowrap\">",
"       g/24",
"      </span>",
"      hours, 95% CI -0.47 to -0.10), and hemoglobin value (mean difference of -1.3",
"      <span class=\"nowrap\">",
"       g/dL,",
"      </span>",
"      95% CI -.57 to -1.02) and an increased incidence of hyperkalemia (RR 3.76, 95% CI 1.89-7.43).",
"     </li>",
"     <li>",
"      No definitive conclusions with respect to GFR and allograft loss could be reached when angiotensin converting enzyme inhibitors were compared with placebo or no treatment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several retrospective studies in patients with chronic allograft nephropathy have reported benefits with these agents in terms of slowing the progression of renal failure and possibly mortality. This is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/61/34778?source=see_link\">",
"     \"Chronic renal allograft nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A double-blind, randomized, placebo-controlled trial compared the effect of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/35/26168?source=see_link\">",
"     losartan",
"    </a>",
"    , 100 mg (n = 77), or placebo (n = 76) initiated within three months of transplantation and continuing for five years [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/76\">",
"     76",
"    </a>",
"    ]. The composite outcome included doubling of the fraction of renal cortical volume occupied by interstitium (or &ldquo;interstitial expansion&rdquo;, which is a measure of interstitial fibrosis and tubular atrophy",
"    <span class=\"nowrap\">",
"     [IF/TA])",
"    </span>",
"    at five years, or ESRD from",
"    <span class=\"nowrap\">",
"     IF/TA",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/76\">",
"     76",
"    </a>",
"    ]. Use of losartan tended to be protective with an odds ratio (OR) of 0.39 (95% CI 0.13&ndash;1.15, p = 0.08). However, losartan had no significant effect on time to a composite of ESRD, death, or doubling of creatinine level. The mean time to doubling of serum creatinine was longer in the losartan group compared with placebo (1065 versus 450 days, HR, 7.28 [95% CI 2.22&ndash;32.78]). In a secondary analysis, losartan appeared to reduce the risk of a composite endpoint including of doubling of interstitial volume or all-cause ESRD (OR 0.36, 95% CI 0.13&ndash;0.99). Blood pressure, GFR, and serum creatinines did not differ between groups, possibly due to the small number of patients enrolled.",
"   </p>",
"   <p>",
"    As with ACE inhibitors, ARBs may also be used in the treatment of posttransplant erythrocytosis and can cause anemia in some patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/38/10857?source=see_link\">",
"     \"Erythrocytosis following renal transplantation\"",
"    </a>",
"    .) For patients with gout, ARBs have the additional advantage of modestly lowering the plasma uric acid concentration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/14/3303?source=see_link\">",
"     \"Hyperuricemia and gout in renal transplant recipients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Given these issues, we prefer to wait three to six months post-transplantation for the institution of an ACE inhibitor or an ARB, if indicated. After this period, the risk of rejection is minimal and significant anemia has likely resolved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Patient is not taking a calcineurin inhibitor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertensive patients not taking",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"      cyclosporine",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"      tacrolimus",
"     </a>",
"    </span>",
"    should be started on antihypertensive medications. Calcium channel blockers, ACE inhibitors, and beta-blockers all may be effective in this setting. A diuretic may also be necessary in patients with allograft dysfunction in whom volume expansion often contributes to the rise in blood pressure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Resistant hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with resistant hypertension should undergo renal arteriography to exclude renal artery stenosis unless there are findings (such as renal insufficiency and an active urine sediment) suggesting possible recurrence of the primary disease. Angioplasty (with or without stenting) or surgery is indicated if a significant stenosis is found. In the absence of renovascular disease, recurrent disease, or rejection, consideration should be given to removal of the native kidneys if there is no other way to control the hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16761/abstract/77,78\">",
"     77,78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23739452\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Posttransplant hypertension occurs in up to 80 percent of renal transplant recipients. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Posttransplant hypertension may be due to recipient or donor factors, to immunosuppressive medications such as calcineurin inhibitors and steroids, or to renal artery stenosis, which can occur in up to 20 percent of renal transplant recipients. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Risk factors and pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Renal artery stenosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Renal transplant artery stenosis is important to identify because it is a correctable form of hypertension. Risk factors include difficulties in harvesting and operative techniques, atherosclerotic disease, cytomegalovirus (CMV) infection, and delayed allograft function. Persistent uncontrolled hypertension, flash pulmonary edema, and an acute elevation in blood pressure are common features of this disorder. Arteriography is the preferred diagnostic modality but Doppler ultrasonography, CT angiography, or magnetic resonance arteriography may also be used to diagnose renal artery stenosis.",
"      <br/>",
"      <br/>",
"      However, the administration of gadolinium during MR imaging has been strongly linked to nephrogenic systemic fibrosis among patients with moderate to severe renal disease. Gadolinium-based imaging should be avoided, if possible, in patients with an estimated glomerular filtration rate less than 30",
"      <span class=\"nowrap\">",
"       mL/min.",
"      </span>",
"      There is no consensus among experts concerning the decision to administer gadolinium among patients with an estimated glomerular filtration rate between 30 and 60",
"      <span class=\"nowrap\">",
"       mL/min.",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Renal artery stenosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31082?source=see_link\">",
"       \"Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Goal blood pressure is",
"      <span class=\"nowrap\">",
"       130/80",
"      </span>",
"      mmHg in patients without diabetes or proteinuria and",
"      <span class=\"nowrap\">",
"       125/75",
"      </span>",
"      mmHg in those with diabetes or proteinuria. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Definitions and goals of therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All classes of anti-hypertensive agents may be used with certain caveats. The dihydropyridine calcium channel blockers",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/16/12554?source=see_link\">",
"       diltiazem",
"      </a>",
"      , nitrendipine, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"       verapamil",
"      </a>",
"      diminish the metabolism of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"       sirolimus",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/4/6218?source=see_link\">",
"       everolimus",
"      </a>",
"      , and should be avoided if possible. However,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12377?source=see_link\">",
"       nifedipine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/18/296?source=see_link\">",
"       amlodipine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/45/2775?source=see_link\">",
"       felodipine",
"      </a>",
"      do not affect the metabolism of cyclosporine, tacrolimus, sirolimus and everolimus significantly.",
"      <br/>",
"      <br/>",
"      If possible, angiotensin converting enzyme inhibitors and angiotensin receptor should be avoided initially in order to avoid confusion in interpretation of a rise in serum creatinine that may suggest acute rejection or hyperkalemia. However the use of such agents after three months may be beneficial. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/1\">",
"      Kasiske BL, Anjum S, Shah R, et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004; 43:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/2\">",
"      Paoletti E, Gherzi M, Amidone M, et al. Association of arterial hypertension with renal target organ damage in kidney transplant recipients: the predictive role of ambulatory blood pressure monitoring. Transplantation 2009; 87:1864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/3\">",
"      Mangray M, Vella JP. Hypertension after kidney transplant. Am J Kidney Dis 2011; 57:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/4\">",
"      Rigatto C, Foley R, Jeffery J, et al. Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol 2003; 14:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/5\">",
"      Hern&aacute;ndez D. Left ventricular hypertrophy after renal transplantation: new approach to a deadly disorder. Nephrol Dial Transplant 2004; 19:1682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/6\">",
"      Mange KC, Feldman HI, Joffe MM, et al. Blood pressure and the survival of renal allografts from living donors. J Am Soc Nephrol 2004; 15:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/7\">",
"      de Vries AP, Bakker SJ, van Son WJ, et al. Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally. Am J Transplant 2004; 4:1675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/8\">",
"      Fern&aacute;ndez-Fresnedo G, Escallada R, Martin de Francisco AL, et al. Association between pulse pressure and cardiovascular disease in renal transplant patients. Am J Transplant 2005; 5:394.",
"     </a>",
"    </li>",
"    <li>",
"     Sayegh, MH, Lazarus, JM. Renal parenchymal disease and hypertension. In: Current Management of Hypertension and Vascular Disease, Cooke, JP, Frohlich, ED (Eds), Decker, Philadelphia 1992. p.76.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/10\">",
"      First MR, Neylan JF, Rocher LL, Tejani A. Hypertension after renal transplantation. J Am Soc Nephrol 1994; 4:S30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/11\">",
"      Textor SC, Canzanello VJ, Taler SJ, et al. Cyclosporine-induced hypertension after transplantation. Mayo Clin Proc 1994; 69:1182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/12\">",
"      P&eacute;rez Font&aacute;n M, Rodr&iacute;guez-Carmona A, Garc&iacute;a Falc&oacute;n T, et al. Early immunologic and nonimmunologic predictors of arterial hypertension after renal transplantation. Am J Kidney Dis 1999; 33:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/13\">",
"      Audard V, Matignon M, Hemery F, et al. Risk factors and long-term outcome of transplant renal artery stenosis in adult recipients after treatment by percutaneous transluminal angioplasty. Am J Transplant 2006; 6:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/14\">",
"      Cowley AW Jr, Roman RJ. The role of the kidney in hypertension. JAMA 1996; 275:1581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/15\">",
"      Curtis JJ, Luke RG, Dustan HP, et al. Remission of essential hypertension after renal transplantation. N Engl J Med 1983; 309:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/16\">",
"      Guidi E, Menghetti D, Milani S, et al. Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families. J Am Soc Nephrol 1996; 7:1131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/17\">",
"      Guidi E, Cozzi MG, Minetti E, Bianchi G. Donor and recipient family histories of hypertension influence renal impairment and blood pressure during acute rejections. J Am Soc Nephrol 1998; 9:2102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/18\">",
"      Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990; 323:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/19\">",
"      Passauer J, L&auml;ssig G, B&uuml;ssemaker E, et al. Reduced endothelin-1- and nitric oxide-mediated arteriolar tone in hypertensive renal transplant recipients. Kidney Int 2004; 65:1782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/20\">",
"      Hricik DE, Lautman J, Bartucci MR, et al. Variable effects of steroid withdrawal on blood pressure reduction in cyclosporine-treated renal transplant recipients. Transplantation 1992; 53:1232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/21\">",
"      Woodle ES, First MR, Pirsch J, et al. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008; 248:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/22\">",
"      Linas SL, Miller PD, McDonald KM, et al. Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys. N Engl J Med 1978; 298:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/23\">",
"      Bruno S, Remuzzi G, Ruggenenti P. Transplant renal artery stenosis. J Am Soc Nephrol 2004; 15:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/24\">",
"      Shiba N, Chan MC, Kwok BW, et al. Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience. J Heart Lung Transplant 2004; 23:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/25\">",
"      Margreiter R, European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study Group. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet 2002; 359:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/26\">",
"      Gonwa T, Mendez R, Yang HC, et al. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. Transplantation 2003; 75:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/27\">",
"      Takeda Y, Miyamori I, Wu P, et al. Effects of an endothelin receptor antagonist in rats with cyclosporine-induced hypertension. Hypertension 1995; 26:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/28\">",
"      Watschinger B, Sayegh MH. Endothelin in organ transplantation. Am J Kidney Dis 1996; 27:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/29\">",
"      Perico N, Ruggenenti P, Gaspari F, et al. Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 1992; 54:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/30\">",
"      Esteva-Font C, Ars E, Guillen-Gomez E, et al. Ciclosporin-induced hypertension is associated with increased sodium transporter of the loop of Henle (NKCC2). Nephrol Dial Transplant 2007; 22:2810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/31\">",
"      Pouria S, State OI, Wong W, Hendry BM. CMV infection is associated with transplant renal artery stenosis. QJM 1998; 91:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/32\">",
"      Humar A, Matas AJ. Surgical complications after kidney transplantation. Semin Dial 2005; 18:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/33\">",
"      Hricik DE, Browning PJ, Kopelman R, et al. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med 1983; 308:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/34\">",
"      Voiculescu A, Schmitz M, Hollenbeck M, et al. Management of arterial stenosis affecting kidney graft perfusion: a single-centre study in 53 patients. Am J Transplant 2005; 5:1731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/35\">",
"      Sankari BR, Geisinger M, Zelch M, et al. Post-transplant renal artery stenosis: impact of therapy on long-term kidney function and blood pressure control. J Urol 1996; 155:1860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/36\">",
"      Loubeyre P, Abidi H, Cahen R, Tran Minh VA. Transplanted renal artery: detection of stenosis with color Doppler US. Radiology 1997; 203:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/37\">",
"      Baxter GM, Ireland H, Moss JG, et al. Colour Doppler ultrasound in renal transplant artery stenosis: which Doppler index? Clin Radiol 1995; 50:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/38\">",
"      O'neill WC, Baumgarten DA. Ultrasonography in renal transplantation. Am J Kidney Dis 2002; 39:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/39\">",
"      Johnson DB, Lerner CA, Prince MR, et al. Gadolinium-enhanced magnetic resonance angiography of renal transplants. Magn Reson Imaging 1997; 15:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/40\">",
"      Rubin GD. Spiral (helical) CT of the renal vasculature. Semin Ultrasound CT MR 1996; 17:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/41\">",
"      Erley CM, Duda SH, Wakat JP, et al. Noninvasive procedures for diagnosis of renovascular hypertension in renal transplant recipients--a prospective analysis. Transplantation 1992; 54:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/42\">",
"      Shamlou KK, Drane WE, Hawkins IF, Fennell RS 3rd. Captopril renography and the hypertensive renal transplantation patient: a predictive test of therapeutic outcome. Radiology 1994; 190:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/43\">",
"      Reisfeld D, Matas AJ, Tellis VA, et al. Late follow-up of percutaneous transluminal angioplasty for treatment of transplant renal artery stenosis. Transplant Proc 1989; 21:1955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/44\">",
"      Fervenza FC, Lafayette RA, Alfrey EJ, Petersen J. Renal artery stenosis in kidney transplants. Am J Kidney Dis 1998; 31:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/45\">",
"      Ruggenenti P, Mosconi L, Bruno S, et al. Post-transplant renal artery stenosis: the hemodynamic response to revascularization. Kidney Int 2001; 60:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/46\">",
"      Henning BF, Kuchlbauer S, B&ouml;ger CA, et al. Percutaneous transluminal angioplasty as first-line treatment of transplant renal artery stenosis. Clin Nephrol 2009; 71:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/47\">",
"      Sierre SD, Raynaud AC, Carreres T, et al. Treatment of recurrent transplant renal artery stenosis with metallic stents. J Vasc Interv Radiol 1998; 9:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/48\">",
"      Leertouwer TC, Gussenhoven EJ, van Overhagen H, et al. Stent placement for treatment of renal artery stenosis guided by intravascular ultrasound. J Vasc Interv Radiol 1998; 9:945.",
"     </a>",
"    </li>",
"    <li>",
"     Rosenthal, JT. Chapter 7. In: Handbook of kidney transplantation, 2nd ed, Danovitch, GM (Eds), Little, Brown, and Company, Boston 1996. p.130.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/50\">",
"      Gill JS. Cardiovascular disease in transplant recipients: current and future treatment strategies. Clin J Am Soc Nephrol 2008; 3 Suppl 2:S29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/51\">",
"      Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/52\">",
"      EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.2. Cardiovascular risks. Arterial hypertension. Nephrol Dial Transplant 2002; 17 Suppl 4:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/53\">",
"      Sanders CE Jr, Curtis JJ. Role of hypertension in chronic renal allograft dysfunction. Kidney Int Suppl 1995; 52:S43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/54\">",
"      Cheigh JS, Haschemeyer RH, Wang JC, et al. Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival. Am J Hypertens 1989; 2:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/55\">",
"      Paul LC, Benediktsson H. Post-transplant hypertension and chronic renal allograft failure. Kidney Int Suppl 1995; 52:S34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/56\">",
"      Opelz G, D&ouml;hler B, Collaborative Transplant Study. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 2005; 5:2725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/57\">",
"      Mourad G, Ribstein J, Mimran A. Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants. Kidney Int 1993; 43:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/58\">",
"      Ponticelli C, Montagnino G, Aroldi A, et al. Hypertension after renal transplantation. Am J Kidney Dis 1993; 21:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/59\">",
"      Ladefoged SD, Pedersen E, Hammer M, et al. Influence of diltiazem on renal function and rejection in renal allograft recipients receiving triple-drug immunosuppression: a randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant 1994; 9:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/60\">",
"      Ladefoged SD, Andersen CB. Calcium channel blockers in kidney transplantation. Clin Transplant 1994; 8:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/61\">",
"      Midtvedt K, Hartmann A, Foss A, et al. Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. Transplantation 2001; 72:1787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/62\">",
"      Kuypers DR, Neumayer HH, Fritsche L, et al. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study. Transplantation 2004; 78:1204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/63\">",
"      Kovarik JM, Beyer D, Bizot MN, et al. Pharmacokinetic interaction between verapamil and everolimus in healthy subjects. Br J Clin Pharmacol 2005; 60:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/64\">",
"      Cross NB, Webster AC, Masson P, et al. Antihypertensive treatment for kidney transplant recipients. Cochrane Database Syst Rev 2009; :CD003598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/65\">",
"      Lake KD. Management of drug interactions with cyclosporine. Pharmacotherapy 1991; 11:110S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/66\">",
"      Lafayette RA, Mayer G, Meyer TW. The effects of blood pressure reduction on cyclosporine nephrotoxicity in the rat. J Am Soc Nephrol 1993; 3:1892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/67\">",
"      Pichler RH, Franceschini N, Young BA, et al. Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol 1995; 6:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/68\">",
"      Curtis JJ, Laskow DA, Jones PA, et al. Captopril-induced fall in glomerular filtration rate in cyclosporine-treated hypertensive patients. J Am Soc Nephrol 1993; 3:1570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/69\">",
"      Vlahakos DV, Canzanello VJ, Madaio MP, Madias NE. Enalapril-associated anemia in renal transplant recipients treated for hypertension. Am J Kidney Dis 1991; 17:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/70\">",
"      Gaston RS, Julian BA, Curtis JJ. Posttransplant erythrocytosis: an enigma revisited. Am J Kidney Dis 1994; 24:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/71\">",
"      Stigant CE, Cohen J, Vivera M, Zaltzman JS. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy. Am J Kidney Dis 2000; 35:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/72\">",
"      Holgado, R, Anaya, F, Del Castillo, DD. Nephrol Dial Transplant 2001; 16(Suppl 1):82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/73\">",
"      Formica RN Jr, Friedman AL, Lorber MI, et al. A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period. Nephrol Dial Transplant 2006; 21:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/74\">",
"      Paoletti E, Cassottana P, Amidone M, et al. ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial. Am J Kidney Dis 2007; 50:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/75\">",
"      Hiremath S, Fergusson D, Doucette S, et al. Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transplant 2007; 7:2350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/76\">",
"      Ibrahim HN, Jackson S, Connaire J, et al. Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol 2013; 24:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/77\">",
"      Curtis JJ, Luke RG, Diethelm AG, et al. Benefits of removal of native kidneys in hypertension after renal transplantation. Lancet 1985; 2:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16761/abstract/78\">",
"      Fricke L, Doehn C, Steinhoff J, et al. Treatment of posttransplant hypertension by laparoscopic bilateral nephrectomy? Transplantation 1998; 65:1182.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7360 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-200.215.4.194-84581B2B62-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_23_16761=[""].join("\n");
var outline_f16_23_16761=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23739452\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RISK FACTORS AND PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Role of glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Role of calcineurin inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RENAL ARTERY STENOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Arteriography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Spiral CT angiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Radioisotope renography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Angioplasty",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DEFINITIONS AND GOALS OF THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Patient is taking a calcineurin inhibitor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Calcium channel blockers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - ACE inhibitors/ARBs and other agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Patient is not taking a calcineurin inhibitor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Resistant hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23739452\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7360\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7360|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/42/38573\" title=\"figure 1\">",
"      Cyclosporine and Ca blockers",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/61/34778?source=related_link\">",
"      Chronic renal allograft nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17959?source=related_link\">",
"      Clinical implications and treatment of left ventricular hypertrophy in hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41945?source=related_link\">",
"      Cyclosporine and tacrolimus nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/38/10857?source=related_link\">",
"      Erythrocytosis following renal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/17/31001?source=related_link\">",
"      Establishing the diagnosis of renovascular hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/60/9159?source=related_link\">",
"      Genetic factors in the pathogenesis of essential hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/14/3303?source=related_link\">",
"      Hyperuricemia and gout in renal transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/43/43706?source=related_link\">",
"      Maintenance immunosuppressive therapy in renal transplantation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31082?source=related_link\">",
"      Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/60/19398?source=related_link\">",
"      Renal effects of ACE inhibitors in hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/45/21210?source=related_link\">",
"      Treatment of hypertension in patients with diabetes mellitus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_23_16762="Surgical oncologic principles for the resection of colon cancer";
var content_f16_23_16762=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surgical oncologic principles for the resection of colon cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/23/16762/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/23/16762/contributors\">",
"     Miguel A Rodriguez-Bigas, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/23/16762/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/23/16762/contributors\">",
"     Kenneth K Tanabe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/23/16762/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/23/16762/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/23/16762/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H125357644\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A surgical resection is the only curative modality for localized colon cancer. Surgery also provides a potentially curative option for selected patients with limited metastatic disease in the liver",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lung. Furthermore, even patients who are not candidates for a curative resection can benefit from surgical palliation for symptoms of obstruction and bleeding from the primary tumor.",
"   </p>",
"   <p>",
"    The specific operative procedures to treat colon cancer, the role of chemotherapy and radiation therapy, and the prognosis are reviewed as separate topics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125358553\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations and diagnostic evaluations for colon cancer are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125364929\">",
"    <span class=\"h1\">",
"     STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The TNM staging classification for colon cancer is reviewed elsewhere (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\", section on 'Staging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125358007\">",
"    <span class=\"h1\">",
"     GENERAL SURGICAL PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of a colectomy for cancer is complete removal of the tumor, the major vascular pedicles, and the lymphatic drainage basin of the affected colonic segment (",
"    <a class=\"graphic graphic_figure graphicRef64156 \" href=\"UTD.htm?13/22/13670\">",
"     figure 1",
"    </a>",
"    ). Although segmental resection alone may be sufficient for primary tumor removal, wider resection is required to achieve a sufficient lymphadenectomy. The blood vessels are divided at their origin in order to obtain a wide resection and maximize the number of lymph nodes removed.",
"   </p>",
"   <p>",
"    Restoration of bowel continuity by means of a tension-free primary anastomosis is the goal for patients undergoing an uncomplicated colectomy. En bloc resection of contiguous structures is indicated if there is attachment or infiltration of the tumor into any organ or structure. (See",
"    <a class=\"local\" href=\"#H125363021\">",
"     'Multivisceral resection'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    If postoperative radiation therapy is anticipated, the omentum is mobilized to protect the small bowel and the radiopaque clips are placed in the tumor bed to mark the operative field. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30489?source=see_link&amp;anchor=H17949594#H17949594\">",
"     \"Overview of the management of primary colon cancer\", section on 'Benefit of postoperative RT'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125358035\">",
"    <span class=\"h2\">",
"     Resection margins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proximal and distal resection margins should be at least 5 cm from the tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/1\">",
"     1",
"    </a>",
"    ]. These margins should allow for an adequate resection of the appropriate segment of the bowel with its vascular supply and associated lymphatics. For patients undergoing right hemicolectomy, the length of ileum resected does not influence local recurrence rates [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H125358679\">",
"     'Right colectomy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125358042\">",
"    <span class=\"h2\">",
"     Regional lymphadenectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional mesenteric lymph nodes include those nodes along the course of major mesenteric vessels and the vascular arcades of the marginal artery, as well as those adjacent to the colon along its mesocolic border, as illustrated in the following table (",
"    <a class=\"graphic graphic_table graphicRef51172 \" href=\"UTD.htm?41/46/42731\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Regional lymphadenectomy provides prognostic information and guides postoperative management, such as chemotherapy administration. There is a direct correlation between the number of lymph nodes evaluated per patient after surgical resection and survival [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/3\">",
"     3",
"    </a>",
"    ]. In addition, the consensus guidelines recommend that at least 12 lymph nodes be assessed for adequate staging [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/1,4-6\">",
"     1,4-6",
"    </a>",
"    ]. The American Society of Clinical Oncology (ASCO) encourages the use of adjuvant chemotherapy for patients with node-negative colon cancer if there are fewer than 12 nodes in the surgical specimen [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/55/30586?source=see_link&amp;anchor=H589530438#H589530438\">",
"     \"Adjuvant chemotherapy for resected stage II colon cancer\", section on 'Summary and recommendations from expert groups'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinical, pathological, and molecular variables contribute to the total number of lymph nodes recovered for patients with colorectal cancer, independent of surgical resection technique and pathologist counting (operator-independent variables). In a review of two prospective cohort databases that included 918 patients undergoing a colorectal cancer resection, there was a 1.09-fold increase (95% CI 1.05-1.13) in total number of lymph nodes recovered per each 10 cm increase in specimen length [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/8\">",
"     8",
"    </a>",
"    ]. In addition, for every 5 cm increase in tumor size, there was a 1.29-fold increase (1.14-1.46) in total lymph node count. Cancers located in the ascending colon, colorectal cancers with a KRAS mutation, and node negative specimens were associated with the greatest number of total lymph nodes recovered. Further evaluation of the relationship between KRAS mutations and total node count is warranted. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/33/30234?source=see_link&amp;anchor=H11#H11\">",
"     \"Molecular genetics of colorectal cancer\", section on 'Ras'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125358049\">",
"    <span class=\"h2\">",
"     Sentinel node mapping",
"    </span>",
"    &nbsp;&mdash;&nbsp;The utility of sentinel lymph node (SLN) mapping for patients with colon cancer has not been established, although this procedure has had clinical impact on the management of other malignancies (eg, breast, melanoma). Upstaging is reported in 11 to 29 percent of patients with node-negative (by standard H&amp;E) colon cancer when the LNs are studied by IHC",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    molecular techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/9-11\">",
"     9-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Furthermore, not all investigators report success with SLN mapping in colon cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/12\">",
"     12",
"    </a>",
"    ]. In both single-institution and multi-institution studies, multilevel sectioning of SLNs failed to predict the presence of nodal disease (as determined by the status of nonsentinel nodes in the resection specimen) in a significant number of patients, particularly those with stage",
"    <span class=\"nowrap\">",
"     T3/4",
"    </span>",
"    disease (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/13-16\">",
"     13-16",
"    </a>",
"    ]. These data suggest that SLN mapping by itself may not improve the accuracy of nodal staging in colon cancer.",
"   </p>",
"   <p>",
"    In recognition of the uncertainty that surrounds their prognostic significance, the 2010 TNM staging classification codes isolated tumor cell nodal micrometastases as pN0 disease (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 1",
"    </a>",
"    ), whether detected by standard histologic techniques, IHC, or PCR [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/2\">",
"     2",
"    </a>",
"    ]. However, the subscript (i+) should be annotated in the staging. This subscript is defined as isolated tumor cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=see_link&amp;anchor=H16#H16\">",
"     \"Pathology and prognostic determinants of colorectal cancer\", section on 'Nodal micrometastases'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125365010\">",
"    <span class=\"h1\">",
"     PREOPERATIVE PREPARATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125365066\">",
"    <span class=\"h2\">",
"     Bowel preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bowel preparation prior to a colon resection includes both prophylactic antibiotics and mechanical cleansing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125365122\">",
"    <span class=\"h3\">",
"     Antimicrobial prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/53/11094?source=see_link\">",
"     cefoxitin",
"    </a>",
"    , or ciprofloxan plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    are administered to most patients (",
"    <a class=\"graphic graphic_table graphicRef65369 \" href=\"UTD.htm?23/52/24397\">",
"     table 3",
"    </a>",
"    ). We do not use oral antibiotics or continue prophylaxis postoperatively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18806?source=see_link\">",
"     \"Control measures to prevent surgical site infection following gastrointestinal procedures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The antimicrobial prophylaxis for prevention of surgical site infection is administered 0 to 2 hours prior to making the incision to begin the colectomy (",
"    <a class=\"graphic graphic_table graphicRef79097 \" href=\"UTD.htm?22/46/23275\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of control measures to prevent surgical site infection\", section on 'Timing of prophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125365129\">",
"    <span class=\"h3\">",
"     Mechanical bowel preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend not using a mechanical bowel preparation (MBP) for elective, open right- and left-sided colectomies and suggest not using MBP for elective laparoscopic colectomy. In meta-analyses of randomized trials of open elective colorectal surgery, omission of MBP was not associated with an increased risk of anastomotic leak or surgical site infection [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/17\">",
"     17",
"    </a>",
"    ]. Although MBP is generally safe, it is associated with rare serious complications (eg, electrolyte imbalances, dehydration) in patients with cardiac and renal disease, as well as healthy patients, and most patients find MBP unpleasant.",
"   </p>",
"   <p>",
"    Based upon the results of 14 randomized trials and 8 meta-analyses, the Canadian Society of Colon and Rectal Surgeons issued the following recommendations regarding MBP for patients undergoing elective colorectal surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/17\">",
"     17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients undergoing an elective open right-sided colorectal surgery, the MBP should be omitted.",
"     </li>",
"     <li>",
"      For patients undergoing elective open left-sided colorectal surgery, the MBP should be omitted.",
"     </li>",
"     <li>",
"      There is insufficient evidence to support or refute the omission of MBP in the preoperative management of patients undergoing elective low anterior resections with or without diverting ileostomy.",
"     </li>",
"     <li>",
"      There is insufficient evidence to support or refute the omission of MBP in the preoperative management of patients undergoing elective laparoscopic colorectal surgery.",
"     </li>",
"     <li>",
"      For patients undergoing elective colorectal surgery, a normal diet may be consumed on the day prior to surgery.",
"     </li>",
"     <li>",
"      There is insufficient evidence to support or refute the use of enemas in the preoperative management of patients undergoing elective colorectal surgery.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, many surgeons continue to use bowel preparation in select clinical settings (eg, low anterior resection), particularly when solid stool is likely to be present at the site of colonic anastomosis, because removing gross feces facilitates performing an anastomosis. Conversely, the liquid colonic contents that remain after a MBP are more prone to spillage and contamination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125365341\">",
"    <span class=\"h2\">",
"     Venous thromboembolism prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients undergoing intra-abdominal surgery are at a moderate to high risk for developing a deep venous thrombosis (DVT) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/18\">",
"     18",
"    </a>",
"    ]. All patients scheduled for colonic resection should receive primary prophylaxis. The measures currently available for VTE prophylaxis in surgical patients include low dose unfractionated",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    , low molecular weight (LMW) heparin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/35/40503?source=see_link\">",
"     fondaparinux",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    , intermittent pneumatic compression (IPC)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    graduated compression stockings (GCS) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/19\">",
"     19",
"    </a>",
"    ] and, where available, oral factor Xa or factor IIa (thrombin) inhibitors. Prevention of DVT is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=see_link\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125365348\">",
"    <span class=\"h2\">",
"     Preoperative vaccination",
"    </span>",
"    &nbsp;&mdash;&nbsp;For settings where the surgeon anticipates a splenectomy with the left hemicolectomy (eg, large splenic flexure cancers, local invasion of the spleen), vaccines to protect against Streptococcus pneumonia, Haemophilus influenza type B, and Neisseria meningitides should be administered at least 14 days before the operation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1177?source=see_link&amp;anchor=H4#H4\">",
"     \"Prevention of sepsis in the asplenic patient\", section on 'Immunizations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125358593\">",
"    <span class=\"h1\">",
"     SURGICAL PROCEDURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125358679\">",
"    <span class=\"h2\">",
"     Right colectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A right hemicolectomy is usually performed for cancer of the cecum and ascending colon, and for some hepatic flexure cancers (",
"    <a class=\"graphic graphic_figure graphicRef70995 \" href=\"UTD.htm?24/61/25556\">",
"     figure 2",
"    </a>",
"    ). The general principles for performing the operative procedure are described elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/23/28024?source=see_link\">",
"     \"Right and extended right colectomy: Open technique\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125358701\">",
"    <span class=\"h2\">",
"     Extended right colectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;An extended right colectomy is typically performed for cancer of the hepatic flexure and proximal transverse colon (",
"    <a class=\"graphic graphic_figure graphicRef51067 \" href=\"UTD.htm?25/39/26228\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/20\">",
"     20",
"    </a>",
"    ]. The general principles for performing the operative procedure are described elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/23/28024?source=see_link\">",
"     \"Right and extended right colectomy: Open technique\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125358708\">",
"    <span class=\"h2\">",
"     Transverse colectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A transverse colectomy may be undertaken for mid-transverse colon cancers as long as satisfactory resection margins and an adequate lymphadenectomy can be obtained (",
"    <a class=\"graphic graphic_figure graphicRef69341 \" href=\"UTD.htm?19/24/19844\">",
"     figure 4",
"    </a>",
"    ). The transverse colon is resected along with the middle colic vessels and its mesentery (",
"    <a class=\"graphic graphic_figure graphicRef73756 \" href=\"UTD.htm?40/32/41479\">",
"     figure 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef58219 \" href=\"UTD.htm?38/33/39448\">",
"     figure 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Transverse colectomy is a procedure that is uncommonly performed as cancers are generally either to the right or left of the midline, and therefore, a right or a left hemicolectomy should be performed to achieve an adequate lymphadenectomy. In the case of &ldquo;true&rdquo; mid-transverse cancers, a transverse colectomy can be performed. However, the surgeon must be cognizant that an adequate lymphadenectomy is being performed and that there will be no tension at the anastomosis. If any of these factors are not met, the patient is best served by an extended right or left hemicolectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125358715\">",
"    <span class=\"h2\">",
"     Left colectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A left hemicolectomy is appropriate for tumors in the distal transverse or descending colon and for selected patients with proximal sigmoid colon cancer (",
"    <a class=\"graphic graphic_figure graphicRef75381 \" href=\"UTD.htm?40/51/41779\">",
"     figure 7",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef53859 \" href=\"UTD.htm?12/46/13028\">",
"     figure 8",
"    </a>",
"    ). In select patients, a segmental colectomy may be performed as long as adequate resection margins and lymphadenectomy are achieved [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/21\">",
"     21",
"    </a>",
"    ]. The general principles for performing the operative procedure are described elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/16/20744?source=see_link\">",
"     \"Left colectomy: Open technique\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125358722\">",
"    <span class=\"h3\">",
"     Sigmoid colectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For sigmoid colon cancers, segmental or sigmoid colectomy is appropriate. The inferior mesenteric artery is divided at its origin, and dissection proceeds just under the superior rectal vessels toward the pelvis until adequate margins are obtained.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125358729\">",
"    <span class=\"h2\">",
"     Subtotal and total colectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A subtotal or a total abdominal colectomy is indicated if there are synchronous neoplasms on the right and left sides of the colon. Occasionally, these procedures are performed in patients presenting with obstructing left-sided tumors. For patients with hereditary nonpolyposis colorectal cancer (HNPCC) who present with a colon cancer, total abdominal colectomy is the procedure of choice. It is also a procedure that can be used in selected patients with Familial Adenomatous Polyposis and MUTYH associated polyposis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=see_link\">",
"     \"Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/14/16618?source=see_link&amp;anchor=H16#H16\">",
"     \"Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125358736\">",
"    <span class=\"h2\">",
"     Prophylactic oophorectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prophylactic oophorectomy for normal appearing ovaries is not recommended as there are no data that support a survival advantage for the procedure. A population-based cohort study of 4566 women found that the prevalence of ovarian metastases at the time of colon and rectal cancer diagnosis was 1.1 and 0.6 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/22\">",
"     22",
"    </a>",
"    ]. The incidence of metachronous ovarian metastases in women with stage I-III colon or rectal cancer who underwent radical surgery was 1.1 and 0.1 percent, respectively.",
"   </p>",
"   <p>",
"    Resection of clinically apparent ovarian metastases is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19930?source=see_link&amp;anchor=H4#H4\">",
"     \"Locoregional methods for management and palliation in patients who present with stage IV colorectal cancer\", section on 'Ovarian metastases'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125358938\">",
"    <span class=\"h2\">",
"     Locally advanced primary lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 10 percent of patients with colon cancer have invasion of contiguous organs or inflammatory adhesions involving neighboring structures. Guidelines from the National Comprehensive Cancer Network (NCCN), National Cancer Institute (NCI), the American Society of Colon and Rectal Surgeons, as well as quality performance indicators for colorectal cancer surgery developed by an independent group, emphasize that appropriate surgical management for colon cancers that grow through the bowel wall into adjacent structures or organs (eg, T4 disease) (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 1",
"    </a>",
"    ) should include multivisceral resection with a negative margin of the adjacent structure [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/1,5,6,23\">",
"     1,5,6,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125363021\">",
"    <span class=\"h3\">",
"     Multivisceral resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multivisceral resection is associated with improved local control and overall survival [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/24-32\">",
"     24-32",
"    </a>",
"    ]. In some series, long-term outcomes are comparable to those of patients undergoing standard resection who do not have adjacent organ adhesions [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/25,27\">",
"     25,27",
"    </a>",
"    ], although perioperative morbidity rates may be higher [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/25\">",
"     25",
"    </a>",
"    ]. The plane of adherence between the colonic tumor and the adjacent organ(s) should not be disrupted because over 40 percent of these adhesions are malignant [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/31,33\">",
"     31,33",
"    </a>",
"    ], and transection of tumor could further impair prognosis.",
"   </p>",
"   <p>",
"    Despite the benefits of multivisceral en bloc resection for locally advanced disease, this approach is underutilized [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/30\">",
"     30",
"    </a>",
"    ]. In a study derived from the SEER database, only one-third of patients with locally advanced colorectal cancer treated between 1988 and 2002 were managed by multivisceral en bloc resection [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/30\">",
"     30",
"    </a>",
"    ]. These data underscore the need for further education and training of surgeons as well as better preoperative staging and surgical planning, as these patients often need a multidisciplinary approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125359219\">",
"    <span class=\"h3\">",
"     Radiation and chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefit of postoperative radiation therapy and the role of neoadjuvant chemoradiotherapy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30489?source=see_link&amp;anchor=H17949018#H17949018\">",
"     \"Overview of the management of primary colon cancer\", section on 'Neoadjuvant chemoradiotherapy or chemotherapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30489?source=see_link&amp;anchor=H17949594#H17949594\">",
"     \"Overview of the management of primary colon cancer\", section on 'Benefit of postoperative RT'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the surgeon anticipates postoperative radiation therapy, consideration should be given to placing surgical clips at the resected tumor bed margins to better direct therapy. Occasionally, if omentum is available, an omental flap could be utilized to try to exclude small bowel from the radiation field.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125359310\">",
"    <span class=\"h3\">",
"     Obstructed",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optimal management of an obstructing cancer depends upon the condition of the patient and the tumor location. For surgical candidates, operative alternatives for obstructing colon cancers include resection of the tumor with a primary anastomosis with or without a temporary proximal diversion, resection without an anastomosis and with an end colostomy, and proximal diversion with a mucous fistula or a loop colostomy, to temporize the situation with an elective definitive resection at a second operation.",
"   </p>",
"   <p>",
"    In general, the preferred method of treatment is resection of the obstructing lesion and primary anastomosis with or without proximal diversion depending on the location of the tumor and other factors. Primary anastomosis is not performed if there is diffuse peritonitis or free perforation,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    if the patient is medically unstable. Because the right and transverse colon have lower bacterial counts and contain liquid stool, right colectomy or extended right colectomy and primary ileocolonic anastomosis without proximal diversion can be safely performed for obstructing right-sided cancers.",
"   </p>",
"   <p>",
"    On the other hand, many surgeons routinely perform a temporary proximal diverting colostomy following resection of an obstructing left-sided colon cancer. However, some studies suggest that obstructing left-sided lesions can be safely managed with a one-stage procedure, with acceptable morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/34-38\">",
"     34-38",
"    </a>",
"    ]. As an example, in a retrospective study of 243 consecutive patients who underwent emergent surgery for obstructing colon cancer at Queen Mary's Hospital in Hong Kong, there were no statistically significant differences in hospital mortality or anastomotic leak rates among patients who underwent resection and primary anastomosis regardless of tumor location (right- versus left-sided) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another temporizing approach for an obstructing cancer is endoscopic placement of an expandable metal stent. Enteral stenting in the setting of an obstruction from cancer is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/34/5673?source=see_link\">",
"     \"Enteral stents for the management of malignant colorectal obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125359317\">",
"    <span class=\"h3\">",
"     Perforated",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of perforated tumors is individualized. Treatment alternatives depend upon the patient's overall condition and whether peritonitis is localized or generalized. If the patient is stable and peritonitis is not generalized, tumor resection with a primary anastomosis can be performed. Primary anastomosis is not performed in the clinical setting of diffuse peritonitis or free perforation,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    if the patient is medically unstable.",
"   </p>",
"   <p>",
"    For an unstable patient, percutaneous drainage or a proximal diverting colostomy can be performed. However, if drainage is performed, there will be the potential for seeding of the drain tracts; therefore, at the time of definitive resection, an en bloc resection including the abdominal wall with drain tract will need to be performed. Similarly, perforation may cause the tumor to adhere to other organs and an en bloc resection will need to be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125359426\">",
"    <span class=\"h3\">",
"     Benefit of chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of chemotherapy is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30489?source=see_link\">",
"     \"Overview of the management of primary colon cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125359489\">",
"    <span class=\"h2\">",
"     Timing of ostomy closure",
"    </span>",
"    &nbsp;&mdash;&nbsp;If an ostomy was performed at the time of primary colon surgery, the timing of stoma closure depends on various factors. Most importantly, resolution and recovery from the events that led to the decision to create the stoma (eg, perforation, generalized peritonitis, obstruction, and cardiovascular instability) must have taken place. If adjuvant chemotherapy is being administered, closure should be delayed to avoid unnecessary treatment delays. If a primary anastomosis was performed, it must be studied for integrity and patency prior to closure of the stoma.",
"   </p>",
"   <p>",
"    Colonoscopy is indicated prior to closure if the entire colon was not evaluated prior to the stoma formation due to the emergent situation or due to an obstructing tumor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125359496\">",
"    <span class=\"h2\">",
"     Morbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Morbidity associated with open colectomy has been addressed in two large studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a review of 4711 patients undergoing open colectomy with primary anastomosis for colon cancer between 1991 and 1995 at the Veterans Administration (VA) Hospitals, 28 percent experienced at least one complication [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/39\">",
"       39",
"      </a>",
"      ]. The most common were prolonged ileus (7.5 percent), pneumonia (6.2 percent), failure to wean from the ventilator (5.7 percent), and urinary tract infection (5 percent). Thirty-day hospital mortality was 5.7 percent.",
"     </li>",
"     <li>",
"      A more contemporary study included data from the University Health System Consortium Data Base on patients undergoing right (n = 9336) or left (n = 5744) hemicolectomy for colon cancer at academic medical centers between 2002 and 2006 [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/40\">",
"       40",
"      </a>",
"      ]. The overall complication rate was comparable to that reported by the VA study and similar for right and left hemicolectomy (26.8 and 28.3 percent, respectively). The most common complications were wound and pulmonary-related. Thirty-day in-hospital mortality rates were 1.4 and 1.3 percent for right and left hemicolectomy respectively, much lower than in the VA study [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125359503\">",
"    <span class=\"h3\">",
"     Short-term bowel function",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is great variability in the frequency of postoperative bowel movements following a partial colectomy. Most patients will have a minimal increase in frequency, and some have at least a temporary increase to four or more movements per day. Such patients may benefit from the addition of dietary fiber, and when necessary, an antimotility agent. The remaining colon will often adapt over a four to six month period, gradually returning to a more normal bowel pattern.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125359914\">",
"    <span class=\"h1\">",
"     LAPAROSCOPIC COLECTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laparoscopic-assisted colectomy (LAC) was first described in 1991 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/41\">",
"     41",
"    </a>",
"    ]. However, because of concerns over port site recurrences and the adequacy of the oncologic procedure, LAC was not accepted by the surgical community until the completion of multiple studies comparing safety and oncologic equivalency to open colectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125359921\">",
"    <span class=\"h2\">",
"     Survival outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Randomized trials [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/42-48\">",
"     42-48",
"    </a>",
"    ] and meta-analyses [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/49-51\">",
"     49-51",
"    </a>",
"    ] identified no detrimental impact on recurrence or survival for laparoscopic as compared with open colectomy (OC). Three separate meta-analyses have come to the same conclusion. Results from the largest trial and two of the meta-analyses are described below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the largest trial, the United States Intergroup Clinical Outcomes of Surgical Therapy (COST) trial, 872 patients with colonic adenocarcinoma were randomly assigned to OC or LAC by credentialed surgeons, who each performed at least 20 laparoscopic resections and underwent videotape analysis of their technique before enrolling patients on the study [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/43,44\">",
"       43,44",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Operative time was significantly longer in the LAC group (150 versus 95 minutes), and 21 percent of laparoscopic cases required conversion to an open procedure [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/43\">",
"       43",
"      </a>",
"      ]. On the other hand, the LAC group had modestly but significantly shorter durations of hospital stay (five versus six days) and parenteral analgesic use (three versus four days). There were no significant differences with regard to intraoperative or postoperative complications, perioperative mortality rates, readmission or reoperation rates [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/43\">",
"       43",
"      </a>",
"      ], or rate of surgical wound recurrence [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/44\">",
"       44",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      At a median follow-up of seven years, there were also no significant differences in the five-year disease-free survival (69 versus 68 percent in the LAC and open colectomy groups, respectively) or overall survival (76 versus 75 percent).",
"     </li>",
"     <li>",
"      Long-term outcomes from laparoscopic versus open surgery for colorectal cancer have been addressed in two meta-analyses of randomized trials, most of which enrolled exclusively or predominantly patients with colon cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/49,50\">",
"       49,50",
"      </a>",
"      ]. One analyzed results from seven published randomized trials, while the other focused on four trials with the end-point of survival that enrolled more than 150 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/42-45,52\">",
"       42-45,52",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Both concluded that laparoscopic colectomy provides oncologic outcomes (cause-specific survival, disease recurrence, number of lymph nodes harvested) that are comparable to those achieved with an open approach. Of the seven randomized trials reporting this outcome, only three of 826 patients randomized to laparoscopic surgery developed an incisional recurrence, compared with one of 801 patients undergoing open surgery (0.36 versus 0.12 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    LAC is technically more complex than other laparoscopic procedures, such as laparoscopic cholecystectomy, because of the need to work in multiple anatomic regions, division of multiple mesenteric vessels, removal of a fairly large specimen, and performance of an anastomosis. The number of supervised LAC resections needed to master the procedure is not well documented. At least one report enumerating quality indicators for modern colorectal cancer surgery based on expert panel opinion suggests that surgeons should have completed 20 mentored laparoscopic procedures for either cancer or benign disease to be credentialed for LAC, and that they should continue to perform at least 12 cases annually [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/5\">",
"     5",
"    </a>",
"    ]. Consideration for LAC rather than an open colectomy should be given for patients with nonobstructed, nonperforated, non-locally-advanced colon cancers that have not had prior extensive abdominal surgery.",
"   </p>",
"   <p>",
"    Patients with tumors invading adjacent organs or with perforated tumors should not be considered candidates for LAC. Otherwise, the same oncologic principles that apply to open surgery for resectable colon cancer apply to LAC. (See",
"    <a class=\"local\" href=\"#H125363021\">",
"     'Multivisceral resection'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In addition, the surgeon must have a low threshold for converting a LAC to an open procedure when indicated. The reported conversion rate in the trials discussed above varied 11 to 21 percent (with conversion rates decreasing with greater surgeon experience) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/42,43,45,52\">",
"     42,43,45,52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125359928\">",
"    <span class=\"h2\">",
"     Surgical site infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of surgical site infection (SSI) after colorectal surgery for benign and malignant disease was evaluated in a review from the National Surgical Quality Improvement Program (NSQIP) of patients in the database between 2006 and 2007. The overall rate of SSI was significantly lower in 3414 patients undergoing laparoscopic colorectal surgery compared with 7565 patients undergoing an open procedure (9.5 versus 16.1 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients treated by the laparoscopic technique also had a significantly lower morbidity probability score (0.18 versus 0.25), and significantly fewer superficial wound infections (6.6 versus 10.3 percent), deep wound infections (1.0 versus 2.4 percent), organ space infections (2.4 versus 4.3 percent), and wound dehiscence rates (0.85 versus 2.7 percent). The mean operative time was significantly longer for laparoscopic surgery (159 versus 139 minutes).",
"   </p>",
"   <p>",
"    The patients were not stratified for emergency surgery compared with elective surgery. Information on how the patients were chosen for open versus laparoscopic procedures as well as the conversion rate from laparoscopic to open procedures was not reported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H287094127\">",
"    <span class=\"h2\">",
"     Robotic-assisted colectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Robotic-assisted surgical procedures are emerging technologies that combine the advantages of the laparoscopic approach (eg, less postoperative pain, faster recovery) with the advantages of the open approach (eg, high-quality three-dimensional vision, restoration of the eye-hand-target axis) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/54-56\">",
"     54-56",
"    </a>",
"    ]. The disadvantages of robotic surgery include high cost, long intraoperative set-up times, and long procedure times [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/57\">",
"     57",
"    </a>",
"    ]. There are no data from randomized trials comparing survival and disease-related outcomes for procedures performed by the robotic-assisted approach with either the open or the laparoscopic approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125359942\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF ELDERLY PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery for colon cancer (including laparoscopic resection [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]) should not be denied simply based on age. Older patients tend to have more comorbidity and a higher incidence of postoperative morbidity and mortality; otherwise, their prognosis is comparable to that of younger patients.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a systematic review of 28 studies, elderly patients with colorectal cancer presented with later stage disease, were more likely to have emergency surgery, and to undergo a noncurative resection as compared with younger patients [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/60\">",
"       60",
"      </a>",
"      ]. Although elderly patients had significantly lower overall survival rates than those under the age of 65 at the time of resection, age-related differences in cancer-specific survival were much less striking; two-year survival rates for patients &lt;65, 65 to 74, 75 to 84, and &gt;85 years old were 89, 85, 85, and 78 percent, respectively.",
"     </li>",
"     <li>",
"      In a population-based study of 180 Scottish patients aged 80 or older who underwent abdominal surgery for colorectal cancer between 1993 and 1999, 30 percent required an emergency procedure [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/61\">",
"       61",
"      </a>",
"      ]. Major determinants of survival were degree of comorbidity, urgency of the surgical procedure, and stage of the disease. Unfortunately, there were no data regarding the intent of the surgery (whether it was curative or palliative). An important finding was that the majority of patients maintained social independence after surgery.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A comprehensive geriatric assessment may be useful in formulating an appropriate, individualized treatment plan for the elderly patient. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/56/41864?source=see_link\">",
"     \"Comprehensive geriatric assessment for patients with cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Issues surrounding adjuvant chemotherapy in elderly patients are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/51/11066?source=see_link\">",
"     \"Adjuvant therapy for resected colon cancer in elderly patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125359949\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF CARCINOMA IN A POLYP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of colorectal cancers arise from polyps (adenomas). The malignant potential of an adenoma depends on its size, histology, and degree of dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/62\">",
"     62",
"    </a>",
"    ]. It is believed that the transformation from normal mucosa to adenoma, dysplasia, in situ (noninvasive) cancer, and then to invasive cancer takes many years. An invasive cancer, which is defined by penetration of the muscularis mucosa by malignant cells, has the potential to metastasize to lymph nodes and distant sites. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/33/30234?source=see_link&amp;anchor=H3#H3\">",
"     \"Molecular genetics of colorectal cancer\", section on 'The adenoma-carcinoma sequence'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Benign adenomas, as well as those with severe dysplasia or carcinoma in situ (no evidence of invasive cancer), can be effectively managed by endoscopic removal (polypectomy) alone as long as the resection margins are free of cancer. A colonoscopy (or flexible sigmoidoscopy depending on the location of the polyp) should be repeated at three to six months to evaluate the completeness of excision. If there is no evidence of",
"    <span class=\"nowrap\">",
"     persistence/recurrence,",
"    </span>",
"    further management is per practice guidelines. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32746?source=see_link\">",
"     \"Approach to the patient with colonic polyps\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28968?source=see_link\">",
"     \"Endoscopic removal of large colonic polyps\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The American Gastroenterological Association (AGA) guideline for colonoscopy surveillance after polypectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/63\">",
"     63",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/\">",
"     www.gastro.org",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The management of a malignant polyp containing invasive carcinoma must be individualized. Certain characteristics are considered favorable, as they are associated with a decreased incidence of residual cancer",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lymphatic spread. The following studies illustrate these favorable histologic features:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The risk of nodal metastasis is less than 2 percent if the area of invasive cancer is in the head of a pedunculated polyp, the stalk and polypectomy margins are uninvolved, and adverse histologic features are absent (eg, poorly differentiated histology, lymphovascular invasion) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/64,65\">",
"       64,65",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The depth of submucosal invasion in patients with T1 sessile polyps has been correlated with the incidence of lymph node metastases. A retrospective review of 344 patients with sessile T1 polyps lesions who underwent surgical resection where the depth of invasion into the submucosa could be determined, found that the incidence of lymph node metastases was 3, 8, and 23 percent in patients whose sessile lesions invaded the upper, middle, and lower thirds of the submucosa, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/66\">",
"       66",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For the majority of these cases, endoscopic polypectomy alone represents adequate treatment. However, other factors may influence the decision for or against radical surgery, including the patient's tolerance to the possible (albeit small) risk that residual disease may be left behind. The risks and benefits of endoscopic therapy alone must be clearly discussed with each patient.",
"   </p>",
"   <p>",
"    If an endoscopically removed polyp has clinical features that may require surgical resection or surveillance colonoscopy, the endoscopist usually tattoos the area by injecting a permanent surgical marker at the site of the polypectomy. This way, the site can be localized at a later date for follow-up colonoscopy or surgical exploration if there is minimal or no residual disease present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/51/30519?source=see_link\">",
"     \"Tattooing and other methods for localizing colonic lesions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If endoscopic treatment alone is recommended, follow-up colonoscopy should be repeated three months later. If there is no evidence of persistence or recurrence, management should be as per practice guidelines. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32746?source=see_link\">",
"     \"Approach to the patient with colonic polyps\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28968?source=see_link\">",
"     \"Endoscopic removal of large colonic polyps\"",
"    </a>",
"    .) The AGA guideline for colonoscopy surveillance after polypectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/63\">",
"     63",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/\">",
"     www.gastro.org",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125360754\">",
"    <span class=\"h1\">",
"     SURGERY FOR LOCALLY RECURRENT DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolated local and regional recurrences occur in approximately 3 to 12 percent of patients who have undergone a primary colon cancer resection with curative intent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/67-70\">",
"     67-70",
"    </a>",
"    ]. Curative intent is defined as histologically negative margins of resection and no evidence of synchronous distant disease.",
"   </p>",
"   <p>",
"    Locoregional recurrences are classified into four categories: anastomotic,",
"    <span class=\"nowrap\">",
"     mesenteric/nodal,",
"    </span>",
"    retroperitoneal, and peritoneal [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/71\">",
"     71",
"    </a>",
"    ]. Factors associated with recurrence include bowel perforation, fistulization, T3 and T4 size lesions (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 1",
"    </a>",
"    ), emergent surgery, poorly differentiated tumors, and cancers located in the hepatic flexure or sigmoid colon [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/67,69\">",
"     67,69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A subset of patients with isolated recurrent locoregional colon cancer will derive long-term benefit from aggressive surgical resection of the recurrent disease. Patients suspected of having a locoregional recurrence should undergo comprehensive restaging, including a CT scan of the chest, abdomen and pelvis, and a colonoscopy. Because of its greater sensitivity for distant metastatic disease, a PET scan is indicated if staging CT scans are negative [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link&amp;anchor=H18#H18\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\", section on 'PET scans'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with an isolated locoregional recurrence should be evaluated for a salvage resection. The most important prognostic factor is the ability to achieve an R0 resection (microscopic negative margins). In two prospective studies, five-year survival for patients who were able to undergo R0 resection was 43 and 57 percent, respectively, versus &lt;5 percent for those with an incomplete or no resection [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/69,71\">",
"     69,71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125360761\">",
"    <span class=\"h2\">",
"     Locally recurrent colon cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with locally recurrent colon cancer that is amenable to a surgical resection should be treated with a resection. Surgical management of patients with concurrent local recurrence and metastatic disease (eg, liver) should be based upon resectability of both sites and patient symptoms. Systemic therapy and management of metastatic colon cancer is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link&amp;anchor=H20#H20\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\", section on 'Systemic chemotherapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44058?source=see_link\">",
"     \"Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44554?source=see_link\">",
"     \"Systemic chemotherapy for metastatic colorectal cancer: Completed clinical trials\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125360768\">",
"    <span class=\"h2\">",
"     Management after local surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there are no prospective trials to guide therapy, the management of these patients is typically multidisciplinary and may include chemotherapy, chemoradiotherapy, or intraoperative radiation therapy, in addition to surgery.",
"   </p>",
"   <p>",
"    While guidelines from the National Comprehensive Cancer Network (NCCN) recommend six months of adjuvant chemotherapy after resection of colorectal cancer liver metastases, they do not address the utility of chemotherapy after resection of a local recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?16/23/16762/abstract/23\">",
"     23",
"    </a>",
"    ]. The decision must be individualized, and is based, in part, on whether adjuvant therapy (particularly an oxaliplatin-containing regimen) was administered previously. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link&amp;anchor=H20#H20\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\", section on 'Systemic chemotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/27/19890?source=see_link\">",
"       \"Patient information: Colon and rectal cancer (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/9/38034?source=see_link\">",
"       \"Patient information: Colectomy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?6/0/6148?source=see_link\">",
"       \"Patient information: Colon and rectal cancer (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?39/22/40293?source=see_link\">",
"       \"Patient information: Colorectal cancer treatment; metastatic cancer (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H125361289\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A surgical resection is the only curative modality for localized colon cancer.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend not using a mechanical bowel preparation (MBP) for elective,",
"      <strong>",
"       open",
"      </strong>",
"      right- and left-sided colectomies (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Regardless if a MBP is used or not, patients should receive antibiotic prophylaxis (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"       metronidazole",
"      </a>",
"      ) as a component of the preparation. We suggest not using MBP for elective laparoscopic colectomy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H125365010\">",
"       'Preoperative preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest laparoscopic-assisted colectomy rather than open colectomy for patients with nonobstructed, nonperforated, non-locally-advanced colon cancers who have not had prior extensive abdominal surgery (",
"      <a class=\"grade\" href=\"._grade_4?title=Grade 2A\">",
"       Grade 2A",
"      </a>",
"      ). In experienced hands, appropriately selected patients have comparable oncologic outcomes, perioperative morbidity and mortality, and faster recovery with laparoscopic as compared with open surgery. (See",
"      <a class=\"local\" href=\"#H125359914\">",
"       'Laparoscopic colectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Regardless of whether a laparoscopic or open colectomy is performed, the surgical specimen should contain at least 12 lymph nodes. Fewer nodes should prompt consideration of adjuvant chemotherapy, even if the patient has stage II (lymph node-negative) disease (",
"      <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H125358042\">",
"       'Regional lymphadenectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sentinel lymph node mapping is not sufficiently accurate to replace regional lymphadenectomy. (See",
"      <a class=\"local\" href=\"#H125358049\">",
"       'Sentinel node mapping'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend not performing a prophylactic bilateral oophorectomy in women with potentially resectable colon or rectal cancer and normal-appearing ovaries (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H125358736\">",
"       'Prophylactic oophorectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The management of obstructed tumors depends upon the condition of the patient and the tumor location (see",
"      <a class=\"local\" href=\"#H125359310\">",
"       'Obstructed'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The preferred treatment for left-sided tumors is resection and primary anastomosis with or without temporary proximal diversion of the fecal stream, if the patient can tolerate it. Stenting for acute malignant colorectal obstruction is an option for patients with obstructing colorectal cancer who require decompression in order to permit elective surgical intervention. Enteral stenting should be reserved for patients who are at increased risk for complications of emergency surgery (eg, patients with multiple significant comorbidities) or who would benefit from having their medical status optimized prior to surgery.",
"     </li>",
"     <li>",
"      Right-sided tumors can usually be managed with resection and a primary anastomosis without a proximal diversion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Management of perforated tumors must be individualized, depending on the condition of the patient and whether peritonitis is localized or generalized. We recommend not performing a primary anastomosis if there is diffuse peritonitis, free perforation, or a medically unstable patient (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). For these cases, temporizing options include percutaneous drainage alone, a temporary diverting colostomy, or placement of a self-expanding metal stent, with a planned later elective resection. (See",
"      <a class=\"local\" href=\"#H125359317\">",
"       'Perforated'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with locally advanced (eg, T4) (",
"      <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"       table 1",
"      </a>",
"      ) tumors that involve contiguous organs or structures, we suggest an en bloc multivisceral resection as needed to obtain negative resection margins of the involved structure (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). &nbsp;(See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30489?source=see_link&amp;anchor=H17949004#H17949004\">",
"       \"Overview of the management of primary colon cancer\", section on 'Locally advanced primary lesions'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The management of invasive cancer in a polyp is individualized based upon the histologic findings. A radical resection, rather than endoscopic polypectomy alone, is performed if any of the following are present :",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Poorly differentiated histology",
"     </li>",
"     <li>",
"      Lymphovascular invasion",
"     </li>",
"     <li>",
"      Cancer at the resection or stalk margin",
"     </li>",
"     <li>",
"      Invasion into the muscularis propria of the bowel wall (T2 lesion)",
"     </li>",
"     <li>",
"      Invasive carcinoma arising in a sessile (flat) polyp with unfavorable features (eg, lower third submucosal penetration, lymphovascular invasion, poorly differentiated)",
"     </li>",
"     <li>",
"      Invasive carcinoma with incomplete polypectomy",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/1\">",
"      Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001; 93:583.",
"     </a>",
"    </li>",
"    <li>",
"     AJCC (American Joint Committee on Cancer) Cancer Staging Manual, 7th edition, Edge, SB, Byrd, DR, Compton, CC, et al (Eds) (Eds), Springer, New York 2010. p.143.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/3\">",
"      Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007; 99:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/4\">",
"      Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/5\">",
"      McGory ML, Shekelle PG, Ko CY. Development of quality indicators for patients undergoing colorectal cancer surgery. J Natl Cancer Inst 2006; 98:1623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/6\">",
"      Otchy D, Hyman NH, Simmang C, et al. Practice parameters for colon cancer. Dis Colon Rectum 2004; 47:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/7\">",
"      Benson AB 3rd, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004; 22:3408.",
"     </a>",
"    </li>",
"    <li>",
"     Data from US Nationwide Prospective Cohort Studies. Predictors of lymph node count in colorectal cancer resections. Arch Surg 2012, 147:715.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/9\">",
"      Bembenek AE, Rosenberg R, Wagler E, et al. Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg 2007; 245:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/10\">",
"      Bilchik AJ, Hoon DS, Saha S, et al. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg 2007; 246:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/11\">",
"      Stojadinovic A, Nissan A, Protic M, et al. Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01. Ann Surg 2007; 245:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/12\">",
"      de Haas RJ, Wicherts DA, Hobbelink MG, et al. Sentinel lymph node mapping in colon cancer: current status. Ann Surg Oncol 2007; 14:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/13\">",
"      Redston M, Compton CC, Miedema BW, et al. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001. J Clin Oncol 2006; 24:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/14\">",
"      Lim SJ, Feig BW, Wang H, et al. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer. Ann Surg Oncol 2008; 15:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/15\">",
"      Faerden AE, Sjo OH, Sjo O, et al. Sentinel node mapping does not improve staging of lymph node metastasis in colonic cancer. Dis Colon Rectum 2008; 51:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/16\">",
"      Cahill RA, Bembenek A, Sirop S, et al. Sentinel node biopsy for the individualization of surgical strategy for cure of early-stage colon cancer. Ann Surg Oncol 2009; 16:2170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/17\">",
"      Eskicioglu C, Forbes SS, Fenech DS, et al. Preoperative bowel preparation for patients undergoing elective colorectal surgery: a clinical practice guideline endorsed by the Canadian Society of Colon and Rectal Surgeons. Can J Surg 2010; 53:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/18\">",
"      Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:381S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/19\">",
"      Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:381S.",
"     </a>",
"    </li>",
"    <li>",
"     Chang GJ and Feig BW. Chapter 11. Cancer of the Colon, Rectum, and Anus. In: The M.D. Anderson Surgical Oncology Handbook, 4th, Feig BW, Berger DH, Fuhrman GM..  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.261.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/21\">",
"      Rouffet F, Hay JM, Vacher B, et al. Curative resection for left colonic carcinoma: hemicolectomy vs. segmental colectomy. A prospective, controlled, multicenter trial. French Association for Surgical Research. Dis Colon Rectum 1994; 37:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/22\">",
"      Segelman J, Fl&ouml;ter-R&aring;destad A, Hellborg H, et al. Epidemiology and prognosis of ovarian metastases in colorectal cancer. Br J Surg 2010; 97:1704.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) guidelines. Available at: www.nccn.org (Accessed on May 15, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/24\">",
"      Lopez MJ. Multivisceral resections for colorectal cancer. J Surg Oncol 2001; 76:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/25\">",
"      Nakafusa Y, Tanaka T, Tanaka M, et al. Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome. Dis Colon Rectum 2004; 47:2055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/26\">",
"      Rowe VL, Frost DB, Huang S. Extended resection for locally advanced colorectal carcinoma. Ann Surg Oncol 1997; 4:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/27\">",
"      Lehnert T, Methner M, Pollok A, et al. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg 2002; 235:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/28\">",
"      Luna-P&eacute;rez P, Rodr&iacute;guez-Ram&iacute;rez SE, De la Barrera MG, et al. Multivisceral resection for colon cancer. J Surg Oncol 2002; 80:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/29\">",
"      Poeze M, Houbiers JG, van de Velde CJ, et al. Radical resection of locally advanced colorectal cancer. Br J Surg 1995; 82:1386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/30\">",
"      Govindarajan A, Coburn NG, Kiss A, et al. Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst 2006; 98:1474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/31\">",
"      Lopez MJ, Monafo WW. Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. Surgery 1993; 113:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/32\">",
"      Hunter JA, Ryan JA Jr, Schultz P. En bloc resection of colon cancer adherent to other organs. Am J Surg 1987; 154:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/33\">",
"      Darakhshan A, Lin BP, Chan C, et al. Correlates and outcomes of tumor adherence in resected colonic and rectal cancers. Ann Surg 2008; 247:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/34\">",
"      Lee YM, Law WL, Chu KW, Poon RT. Emergency surgery for obstructing colorectal cancers: a comparison between right-sided and left-sided lesions. J Am Coll Surg 2001; 192:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/35\">",
"      Chiappa A, Zbar A, Biella F, Staudacher C. One-stage resection and primary anastomosis following acute obstruction of the left colon for cancer. Am Surg 2000; 66:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/36\">",
"      Lau PW, Lo CY, Law WL. The role of one-stage surgery in acute left-sided colonic obstruction. Am J Surg 1995; 169:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/37\">",
"      Omejc M, Stor Z, Jelenc F, Repse S. Outcome after emergency subtotal/total colectomy compared to elective resection in patients with left-sided colorectal carcinoma. Int Surg 1998; 83:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/38\">",
"      Hsu TC. Comparison of one-stage resection and anastomosis of acute complete obstruction of left and right colon. Am J Surg 2005; 189:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/39\">",
"      Longo WE, Virgo KS, Johnson FE, et al. Risk factors for morbidity and mortality after colectomy for colon cancer. Dis Colon Rectum 2000; 43:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/40\">",
"      Hinojosa MW, Konyalian VR, Murrell ZA, et al. Outcomes of right and left colectomy at academic centers. Am Surg 2007; 73:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/41\">",
"      Jacobs M, Verdeja JC, Goldstein HS. Minimally invasive colon resection (laparoscopic colectomy). Surg Laparosc Endosc 1991; 1:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/42\">",
"      Lacy AM, Delgado S, Castells A, et al. The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer. Ann Surg 2008; 248:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/43\">",
"      Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004; 350:2050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/44\">",
"      Fleshman J, Sargent DJ, Green E, et al. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann Surg 2007; 246:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/45\">",
"      Colon Cancer Laparoscopic or Open Resection Study Group, Buunen M, Veldkamp R, et al. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol 2009; 10:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/46\">",
"      Liang JT, Huang KC, Lai HS, et al. Oncologic results of laparoscopic versus conventional open surgery for stage II or III left-sided colon cancers: a randomized controlled trial. Ann Surg Oncol 2007; 14:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/47\">",
"      Leung KL, Kwok SP, Lam SC, et al. Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial. Lancet 2004; 363:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/48\">",
"      Jayne DG, Thorpe HC, Copeland J, et al. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg 2010; 97:1638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/49\">",
"      Bonjer HJ, Hop WC, Nelson H, et al. Laparoscopically assisted vs open colectomy for colon cancer: a meta-analysis. Arch Surg 2007; 142:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/50\">",
"      Jackson TD, Kaplan GG, Arena G, et al. Laparoscopic versus open resection for colorectal cancer: a metaanalysis of oncologic outcomes. J Am Coll Surg 2007; 204:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/51\">",
"      Kuhry E, Schwenk WF, Gaupset R, et al. Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev 2008; :CD003432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/52\">",
"      Jayne DG, Guillou PJ, Thorpe H, et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 2007; 25:3061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/53\">",
"      Kiran RP, El-Gazzaz GH, Vogel JD, Remzi FH. Laparoscopic approach significantly reduces surgical site infections after colorectal surgery: data from national surgical quality improvement program. J Am Coll Surg 2010; 211:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/54\">",
"      Ayav A, Bresler L, Hubert J, et al. Robotic-assisted pelvic organ prolapse surgery. Surg Endosc 2005; 19:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/55\">",
"      Munz Y, Moorthy K, Kudchadkar R, et al. Robotic assisted rectopexy. Am J Surg 2004; 187:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/56\">",
"      Heemskerk J, Zandbergen R, Maessen JG, et al. Advantages of advanced laparoscopic systems. Surg Endosc 2006; 20:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/57\">",
"      Heemskerk J, de Hoog DE, van Gemert WG, et al. Robot-assisted vs. conventional laparoscopic rectopexy for rectal prolapse: a comparative study on costs and time. Dis Colon Rectum 2007; 50:1825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/58\">",
"      Chautard J, Alves A, Zalinski S, et al. Laparoscopic colorectal surgery in elderly patients: a matched case-control study in 178 patients. J Am Coll Surg 2008; 206:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/59\">",
"      Frasson M, Braga M, Vignali A, et al. Benefits of laparoscopic colorectal resection are more pronounced in elderly patients. Dis Colon Rectum 2008; 51:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/60\">",
"      Surgery for colorectal cancer in elderly patients: a systematic review. Colorectal Cancer Collaborative Group. Lancet 2000; 356:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/61\">",
"      Clark AJ, Stockton D, Elder A, et al. Assessment of outcomes after colorectal cancer resection in the elderly as a rationale for screening and early detection. Br J Surg 2004; 91:1345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/62\">",
"      Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36:2251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/63\">",
"      Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006; 130:1872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/64\">",
"      Gordon MS, Cohen AM. Management of invasive carcinoma in pedunculated colorectal polyps. Oncology (Williston Park) 1989; 3:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/65\">",
"      Cranley JP, Petras RE, Carey WD, et al. When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Gastroenterology 1986; 91:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/66\">",
"      Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002; 45:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/67\">",
"      Harris GJ, Church JM, Senagore AJ, et al. Factors affecting local recurrence of colonic adenocarcinoma. Dis Colon Rectum 2002; 45:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/68\">",
"      Willett CG, Tepper JE, Cohen AM, et al. Failure patterns following curative resection of colonic carcinoma. Ann Surg 1984; 200:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/69\">",
"      Sj&ouml;vall A, Granath F, Cedermark B, et al. Loco-regional recurrence from colon cancer: a population-based study. Ann Surg Oncol 2007; 14:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/70\">",
"      Manfredi S, Bouvier AM, Lepage C, et al. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg 2006; 93:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/23/16762/abstract/71\">",
"      Bowne WB, Lee B, Wong WD, et al. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon Rectum 2005; 48:897.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 82949 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-9089A68DA0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_23_16762=[""].join("\n");
var outline_f16_23_16762=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H125361289\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H125357644\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H125358553\">",
"      CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H125364929\">",
"      STAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H125358007\">",
"      GENERAL SURGICAL PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125358035\">",
"      Resection margins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125358042\">",
"      Regional lymphadenectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125358049\">",
"      Sentinel node mapping",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H125365010\">",
"      PREOPERATIVE PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125365066\">",
"      Bowel preparation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H125365122\">",
"      - Antimicrobial prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H125365129\">",
"      - Mechanical bowel preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125365341\">",
"      Venous thromboembolism prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125365348\">",
"      Preoperative vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H125358593\">",
"      SURGICAL PROCEDURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125358679\">",
"      Right colectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125358701\">",
"      Extended right colectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125358708\">",
"      Transverse colectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125358715\">",
"      Left colectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H125358722\">",
"      - Sigmoid colectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125358729\">",
"      Subtotal and total colectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125358736\">",
"      Prophylactic oophorectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125358938\">",
"      Locally advanced primary lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H125363021\">",
"      - Multivisceral resection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H125359219\">",
"      - Radiation and chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H125359310\">",
"      - Obstructed",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H125359317\">",
"      - Perforated",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H125359426\">",
"      - Benefit of chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125359489\">",
"      Timing of ostomy closure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125359496\">",
"      Morbidity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H125359503\">",
"      - Short-term bowel function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H125359914\">",
"      LAPAROSCOPIC COLECTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125359921\">",
"      Survival outcomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125359928\">",
"      Surgical site infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H287094127\">",
"      Robotic-assisted colectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H125359942\">",
"      MANAGEMENT OF ELDERLY PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H125359949\">",
"      MANAGEMENT OF CARCINOMA IN A POLYP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H125360754\">",
"      SURGERY FOR LOCALLY RECURRENT DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125360761\">",
"      Locally recurrent colon cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H125360768\">",
"      Management after local surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H125361289\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/82949\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/82949|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/22/13670\" title=\"figure 1\">",
"      Arterial circulation to the large bowel",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/61/25556\" title=\"figure 2\">",
"      Right colectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/39/26228\" title=\"figure 3\">",
"      Extended right colectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/24/19844\" title=\"figure 4\">",
"      Colectomy for mid transverse colon cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/32/41479\" title=\"figure 5\">",
"      Blood supply to the colon and rectum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/33/39448\" title=\"figure 6\">",
"      Lymphatic drainage of the colon and rectum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/51/41779\" title=\"figure 7\">",
"      Left colon resection for a splenic flexure lesion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/46/13028\" title=\"figure 8\">",
"      Left colectomy for malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/82949|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/26/23982\" title=\"table 1\">",
"      2010 TNM staging colorectal CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/46/42731\" title=\"table 2\">",
"      Reg nodes colorec CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/52/24397\" title=\"table 3\">",
"      Antimicrobial prophylaxis for gastrointestinal surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/46/23275\" title=\"table 4\">",
"      Timing of surgical prophylaxis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/55/30586?source=related_link\">",
"      Adjuvant chemotherapy for resected stage II colon cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/51/11066?source=related_link\">",
"      Adjuvant therapy for resected colon cancer in elderly patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32746?source=related_link\">",
"      Approach to the patient with colonic polyps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=related_link\">",
"      Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/56/41864?source=related_link\">",
"      Comprehensive geriatric assessment for patients with cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18806?source=related_link\">",
"      Control measures to prevent surgical site infection following gastrointestinal procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28968?source=related_link\">",
"      Endoscopic removal of large colonic polyps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/34/5673?source=related_link\">",
"      Enteral stents for the management of malignant colorectal obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/14/16618?source=related_link\">",
"      Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/16/20744?source=related_link\">",
"      Left colectomy: Open technique",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19930?source=related_link\">",
"      Locoregional methods for management and palliation in patients who present with stage IV colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=related_link\">",
"      Management of potentially resectable colorectal cancer liver metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/33/30234?source=related_link\">",
"      Molecular genetics of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30489?source=related_link\">",
"      Overview of the management of primary colon cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=related_link\">",
"      Pathology and prognostic determinants of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/9/38034?source=related_link\">",
"      Patient information: Colectomy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/0/6148?source=related_link\">",
"      Patient information: Colon and rectal cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/27/19890?source=related_link\">",
"      Patient information: Colon and rectal cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/22/40293?source=related_link\">",
"      Patient information: Colorectal cancer treatment; metastatic cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1177?source=related_link\">",
"      Prevention of sepsis in the asplenic patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/23/28024?source=related_link\">",
"      Right and extended right colectomy: Open technique",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44554?source=related_link\">",
"      Systemic chemotherapy for metastatic colorectal cancer: Completed clinical trials",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44058?source=related_link\">",
"      Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/51/30519?source=related_link\">",
"      Tattooing and other methods for localizing colonic lesions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_23_16763="Causes of tall R wave V1 V2";
var content_f16_23_16763=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F53051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F53051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of tall R wave in V1/V2",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Physiologic or positional factors",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Misplacement of chest leads",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Normal variants",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Displacement of heart toward right chest (dextroversion) - congenital or acquired",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Myocardial injury",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Posterior and/or lateral MI myocardial infarction",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Duchenne muscular dystrophy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Ventricular enlargement",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Right ventricular hypertrophy (usually with right axis deviation)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hypertrophic cardiomyopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Altered ventricular depolarization",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Right ventricular conduction abnormalities",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Wolff-Parkinson-White patterns (due to posterior or lateral wall preexcitation)",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_23_16763=[""].join("\n");
var outline_f16_23_16763=null;
var title_f16_23_16764="Family history breast ca risk";
var content_f16_23_16764=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F59120&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F59120&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Family history and risk of breast cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Relative risk estimate (95 percent CI)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any family history",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td>",
"        1.9 (1.7-2.0)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Degree of relatedness",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        First degree (mother, sibling, child)",
"       </td>",
"       <td class=\"sublist_other\">",
"        2.1 (2.0-2.2)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Second degree (grandmother, aunt)",
"       </td>",
"       <td class=\"sublist_other\">",
"        1.5 (1.4-1.6)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Number of relatives",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        One first degree",
"       </td>",
"       <td class=\"sublist_other\">",
"        2.1 (2.0-2.2)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Two first degree",
"       </td>",
"       <td class=\"sublist_other\">",
"        3.6 (2.5-5.0)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Age of relatives breast cancer",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        First degree relative &lt;50",
"       </td>",
"       <td class=\"sublist_other\">",
"        2.3 (2.2-2.5)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        First degree relative &gt;50",
"       </td>",
"       <td class=\"sublist_other\">",
"        1.8 (1.6-2.0)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        First degree relative with bilateral breast cancer",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"       <td>",
"        9.8 (4.0-24.9)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        First degree relative with ovarian cancer",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"       <td>",
"        <p>",
"         1.35 (1.26-1.43) (mother)",
"        </p>",
"        <p>",
"         1.26 (1.13-1.40) (sibling)",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CI: confidence interval.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Pharoah PD, et al. Int J Cancer 1997; 71:800.",
"       </li>",
"       <li>",
"        Slattery ML, et al. JAMA 1993; 270:1563.",
"       </li>",
"       <li>",
"        Hemminki K, et al. Cancer 2011; 117:3972.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_23_16764=[""].join("\n");
var outline_f16_23_16764=null;
var title_f16_23_16765="Integrative approach CAM";
var content_f16_23_16765=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F82394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F82394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Holistic pediatrics: Integrative approach to therapies",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Biochemical therapies",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Medications",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Vitamins and minerals",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Dietary supplements",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Herbs",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Amino acids",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Hormones",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Other",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Fish oil",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Probiotics",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Biomechanical",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Massage and bodywork",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chiropractic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Other spinal adjustments",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Surgery and transfusions",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Bioenergetic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acupuncture",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Therapeutic touch",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Reiki",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Healing touch",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Prayer and ritual",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Homeopathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Radiation therapy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Magnets and electromagnetic field therapies",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Lifestyle therapies",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Diet",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Vegetarian",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Low fat, high fiber",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Hypoallergenic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Macrobiotic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Exercise",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Aerobic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Weight training",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Yoga",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Environment",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Light, music, vibration",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Aromas",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Magnets",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Media",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Social",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Mind-body",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Hypnosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Biofeedback",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Meditation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Counseling, support groups",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Social/communication skills",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_23_16765=[""].join("\n");
var outline_f16_23_16765=null;
var title_f16_23_16766="Contents: Rheumatologic disease";
var content_f16_23_16766=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?43/6/44141\">",
"       Geriatrics",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Rheumatologic disease",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Rheumatologic disease",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Arthroplasty",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/39/1658\">",
"           Complications of total hip arthroplasty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/32/16902\">",
"           Complications of total knee arthroplasty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/55/10106\">",
"           Total hip arthroplasty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/6/17514\">",
"           Total knee arthroplasty",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         General",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/50/7978\">",
"           Clinical manifestations and diagnosis of Paget disease of bone",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/32/13832\">",
"           Clinical manifestations and diagnosis of polymyalgia rheumatica",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/33/18969\">",
"           Clinical manifestations of giant cell (temporal) arteritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/50/34599\">",
"           Diagnosis of giant cell (temporal) arteritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/36/22088\">",
"           Evaluation of the adult with hip pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/59/35769\">",
"           Overview of hyperkyphosis in older persons",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/50/25385\">",
"           Radiologic evaluation of the chronically painful knee in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/39/25210\">",
"           Radiologic evaluation of the painful hip in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/22/10602\">",
"           Treatment of Paget disease of bone",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/26/34217\">",
"           Treatment of giant cell (temporal) arteritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/41/40598\">",
"           Treatment of polymyalgia rheumatica",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gout",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/38/7785\">",
"           Clinical manifestations and diagnosis of calcium pyrophosphate crystal deposition disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/49/4890\">",
"           Clinical manifestations and diagnosis of gout",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/14/6375\">",
"           Pathogenesis and etiology of calcium pyrophosphate crystal deposition disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/26/36266\">",
"           Prevention of recurrent gout",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/24/17800\">",
"           Treatment of acute gout",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/45/18134\">",
"           Treatment of calcium pyrophosphate crystal deposition disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Osteoarthritis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/49/12056\">",
"           Clinical manifestations of osteoarthritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/32/33287\">",
"           Diagnosis and classification of osteoarthritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/0/26630\">",
"           Glenohumeral osteoarthritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/30/2538\">",
"           Nonpharmacologic therapy of osteoarthritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/42/19114\">",
"           Pathogenesis of osteoarthritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/2/40994\">",
"           Patient guidelines for weight-resistance training in osteoarthritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/23/14714\">",
"           Pharmacologic therapy of osteoarthritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/43/29370\">",
"           Risk factors for and possible causes of osteoarthritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/9/12440\">",
"           Surgical therapy of osteoarthritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/28/7621\">",
"           Weight-resistance exercises in patients with osteoarthritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/19/5427\">",
"           Weight-resistance training in patients with osteoarthritis",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-75321033FC-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f16_23_16766=[""].join("\n");
var outline_f16_23_16766=null;
var title_f16_23_16767="Angulated radial neck fracture";
var content_f16_23_16767=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F57116&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F57116&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Angulated radial neck fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 329px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Radial neck fracture angulated 45 degrees in a 14-year-old female.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Erickson M, Frick S. Fractures of the proximal radius and ulna. In: Rockwood and Wilkins' Fractures in Children, 7th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_23_16767=[""].join("\n");
var outline_f16_23_16767=null;
